ClinicalTrials.gov
ClinicalTrials.gov Menu

Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02954874
Recruitment Status : Recruiting
First Posted : November 4, 2016
Last Update Posted : July 16, 2018
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

Brief Summary:
This randomized phase III trial studies how well pembrolizumab works in treating patients with triple-negative breast cancer. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

Condition or disease Intervention/treatment Phase
Estrogen Receptor Negative HER2/Neu Negative Invasive Breast Carcinoma Progesterone Receptor Negative Stage 0 Breast Cancer AJCC v6 and v7 Stage I Breast Cancer AJCC v7 Stage IA Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 Stage II Breast Cancer AJCC v6 and v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Triple-Negative Breast Carcinoma Other: Laboratory Biomarker Analysis Other: Patient Observation Biological: Pembrolizumab Other: Quality-of-Life Assessment Other: Questionnaire Administration Radiation: Radiation Therapy Phase 3

Detailed Description:

PRIMARY OBJECTIVES:

I. To compare invasive disease-free survival (IDFS) of patients with triple-negative breast cancer (TNBC) who have either >= 1 cm residual invasive breast cancer and/or positive lymph nodes (> ypN+) after neoadjuvant chemotherapy randomized to receive 1 year of MK-3475 (pembrolizumab) adjuvant therapy compared to no MK-3475 (pembrolizumab), in both the entire study population and also in the PD-L1 positive subset.

SECONDARY OBJECTIVES:

I. To compare the effects of MK-3475 (pembrolizumab) on overall survival (OS) and distant recurrence-free survival (DRFS) between the two randomized arms for the PD-L1 positive patients and then all patients.

II. To assess the toxicity and tolerability of MK-3475 (pembrolizumab) in this patient population with or without radiation therapy.

TERTIARY OBJECTIVES:

I. To examine the association between biomarkers of inflammation and quality of life and patient reported outcomes between the two groups during and at the end of therapy.

II. To examine the long-term and late effects of treatment on patient-reported outcomes.

III. To collect tissue and whole blood for processing and banking in anticipation of future correlative studies in this patient population.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I (OBSERVATION): Patients receive no treatment but are monitored at standard clinical intervals during first year after randomization. Patients are examined every 12 weeks for 1 year, and every 6 months for 4 years, then annually for 5 years.

ARM II (PEMROLIZUMAB): Patients receive pembrolizumab intravenously (IV) over 30 minutes on days 1 and 22. Courses repeat every 42 days for 52 weeks in the absence of disease progression or unacceptable toxicity.

All patients may undergo radiation therapy within 12 weeks of last breast cancer operation or after treatment.

After completion of study treatment, patients are followed up to 10 years.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1000 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With ≥ 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy
Actual Study Start Date : November 15, 2016
Estimated Primary Completion Date : May 31, 2026

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breast Cancer

Arm Intervention/treatment
Experimental: Arm I (observation)
Patients receive no treatment but are monitored at standard clinical intervals during first year after randomization. Patients are examined every 12 weeks for 1 year, every 6 months for 4 years, and then annually for 5 years. Patients may undergo radiation therapy within 12 weeks of last breast cancer operation or after treatment.
Other: Laboratory Biomarker Analysis
Correlative studies

Other: Patient Observation
Undergo standard monitoring
Other Names:
  • Active Surveillance
  • deferred therapy
  • expectant management
  • observation
  • Watchful Waiting

Other: Quality-of-Life Assessment
Ancillary studies
Other Name: Quality of Life Assessment

Other: Questionnaire Administration
Ancillary studies

Radiation: Radiation Therapy
Undergo radiation therapy
Other Names:
  • Cancer Radiotherapy
  • Irradiate
  • Irradiated
  • irradiation
  • Radiation
  • Radiotherapeutics
  • RADIOTHERAPY
  • RT
  • Therapy, Radiation

Experimental: Arm II (pembrolizumab)
Patients receive pembrolizumab IV over 30 minutes on days 1 and 22. Courses repeat every 42 days for 52 weeks in the absence of disease progression or unacceptable toxicity. Patients may undergo radiation therapy within 12 weeks of last breast cancer operation or after treatment.
Other: Laboratory Biomarker Analysis
Correlative studies

Biological: Pembrolizumab
Given IV
Other Names:
  • Keytruda
  • Lambrolizumab
  • MK-3475
  • SCH 900475

Other: Quality-of-Life Assessment
Ancillary studies
Other Name: Quality of Life Assessment

Other: Questionnaire Administration
Ancillary studies

Radiation: Radiation Therapy
Undergo radiation therapy
Other Names:
  • Cancer Radiotherapy
  • Irradiate
  • Irradiated
  • irradiation
  • Radiation
  • Radiotherapeutics
  • RADIOTHERAPY
  • RT
  • Therapy, Radiation




Primary Outcome Measures :
  1. Invasive disease-free survival (IDFS) [ Time Frame: From date of randomization to date of first invasive recurrence, second invasive primary cancer (breast or not), or death due to any cause, assessed up to 10 years ]
    The distributions of IDFS will be estimated using the Kaplan-Meier method, with 95% confidence intervals (CI) calculated using Greenwood's formula. Comparisons between the two treatment arms will be performed using the stratified log-rank test. The hazard ratios and 95% CIs will be based on the stratified Cox proportional hazard model with treatment as the only covariate. Secondary analyses of IDFS will be performed to describe consistency or divergence across subgroups. This will include a forest plot of treatment hazard ratios and associated 95% confidence intervals for each level of the stratification factors and major prognostic covariates (such as use of radiation therapy). The statistical significance of the interaction between treatment and each stratification factor or prognostic variable will be assessed.

  2. Severity of fatigue measured by Patient Reported Outcomes Measurement Information System (PROMIS) fatigue scale [ Time Frame: 55 weeks after randomization ]
    Will be compared between the two treatment groups by means of multiple linear regression with adjustment for the corresponding baseline measurement as well as whether or not the patient received radiation therapy which is known to be associated with post-treatment fatigue. No multiple comparisons adjustment will be employed since these outcomes evaluate the toxicity of the investigational drug. The clinical meaningfulness of each comparison will be considered.

  3. Physical function reported by patients measured by Patient Reported Outcomes Measurement Information System (PROMIS) Global physical health scale [ Time Frame: 55 weeks after randomization ]
    Will be compared between the two treatment groups by means of multiple linear regression with adjustment for the corresponding baseline measurement as well as whether or not the patient received radiation therapy which is known to be associated with post-treatment fatigue. No multiple comparisons adjustment will be employed since these outcomes evaluate the toxicity of the investigational drug. The clinical meaningfulness of each comparison will be considered.


Secondary Outcome Measures :
  1. Overall survival (OS) [ Time Frame: From date of randomization to date of death due to any cause, assessed up to 10 years ]
    The distributions of OS will be estimated using the Kaplan-Meier method, with 95% CI calculated using Greenwood's formula. Comparisons between the two treatment arms will be performed using the stratified log-rank test. The hazard ratios and 95% CIs will be based on the stratified Cox proportional hazard model with treatment as the only covariate.

  2. Distant recurrence-free survival (DRFS) [ Time Frame: From date of randomization to date of invasive distant disease recurrence, second invasive primary cancer (breast or not) or death due to any cause, assessed up to 10 years ]
    The distributions of DRFS will be estimated using the Kaplan-Meier method, with 95% CI calculated using Greenwood's formula. Comparisons between the two treatment arms will be performed using the stratified log-rank test. The hazard ratios and 95% CIs will be based on the stratified Cox proportional hazard model with treatment as the only covariate.

  3. Incidence of adverse events assessed by National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0 [ Time Frame: Up to 10 years ]
    Toxicity analysis will be conducted in all patients receiving at least one dose of MK-3475 (pembrolizumab). The incidence of adverse events will be reported.

  4. Severity and frequency of treatment-related symptoms (diarrhea, nausea, rash, cough, and shortness of breath, musculoskeletal pain) over time of patients receiving pembrolizumab [ Time Frame: Up to 10 years ]
    Compared without treatment. The distributions of the corresponding Patient Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) items will be compared between the two treatment groups using a mixed ordinal logistic regression model for repeated measures. The model will also include the corresponding baseline measurement and time. Presence of treatment-by-time interaction will be tested for each of these endpoints. Similar analyses will be performed for disease related symptoms. The descriptive and graphical methods suggested in Basch, et. al. will be used to summarize the distributions of different symptoms by treatment group over time.

  5. Emotional function and disease-related symptoms in patients receiving pembrolizumab assessed by Patient Reported Outcomes Measurement Information System (PROMIS) global mental health scale score [ Time Frame: Up to 10 years ]
    Will be compared between the two treatment groups using a mixed model for repeated measures analysis with adjustment for the baseline score and time. Presence of treatment-by-time interaction will be investigated.

  6. Impact of treatment and treatment-related symptoms on physical function in patients without therapy [ Time Frame: 55 weeks after randomization ]
    Compared to patients receiving pembrolizumab. A multiple linear regression model will be performed with physical health scale score as an outcome and treatment and treatment related symptoms as covariates. Presence of treatment by each individual symptom item interactions will be investigated.

  7. Relationship between treatment-related symptoms and adherence to the study medication [ Time Frame: Up to 10 years ]
    Will be investigated among patients randomized to pembrolizumab treatment group by means of multiple logistic regression. Patients who have been on study therapy for 70% or more of their expected time on therapy will be considered adherent.

  8. Resolution of treatment-related symptoms in patients receiving pembrolizumab [ Time Frame: 18 months after randomization ]
    Compared to patients without treatment. A change in severity of the particular symptom will be compared between the two treatment groups by means of multiple linear regression with adjustment for the corresponding measurement at the 55 week assessment point.

  9. Long-term quality of life and symptoms between the two treatment groups [ Time Frame: Up to 60 months after randomization ]
    Mixed models for repeated measures analysis will be used with adjustment for scores at 18 months to examine changes in physical and emotional domain scores, fatigue and other persistent symptoms over the course

  10. Role of pro-inflammatory cytokines in the development of pembrolizumab associated symptoms [ Time Frame: Up to 55 weeks ]
    Specifically focused on treatment-associated fatigue. This will be compared to patients in the observation group.

  11. Single nucleotide polymorphisms (SNPs) in the promotor region of pro-inflammatory cytokine genes and the risk for development and severity of treatment-associated fatigue and other symptoms [ Time Frame: Up to 10 years ]
    The role of these SNPs in the persistence of long-term fatigue in all patients will also be explored using treatment assignment as a covariate.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • STEP 1 REGISTRATION
  • Patients must have histologically confirmed estrogen receptor (ER)-, progesterone receptor (PR)- and HER2-negative (triple-negative, TNBC) or ER, PR, and HER2 equivocal status and must not have received and not be planning to receive adjuvant anti-HER2 or endocrine therapies after completion of neoadjuvant chemotherapy; patients who are HER2 positive by American Society of Clinical Oncology (ASCO) College of American Pathologists (CAP) guidelines are ineligible; HER2 negative and HER2 equivocal cases as per ASCO CAP guidelines that do not receive HER2-targeted therapy are eligible; patients with weekly ER or PR positive disease, defined as ER and/or PR < 5% by immunohistochemistry, are eligible if the treating physician considers the patient not eligible for adjuvant endocrine therapy; residual disease must be >= 1 cm in greatest dimension, and/or have positive lymph nodes (ypN+) observed on pathologic exam

    • NOTE: Immunohistochemistry (IHC)-positive isolated tumor cells in the lymph node (N0 [i+]) are not considered node-positive and these patients also must have >= 1 cm residual invasive cancer in the breast in order to be eligible
  • Patients must not have metastatic disease (i.e., must be M0); patients must not have locally recurrent disease
  • It is preferred that axillary lymph node sampling is performed after completion of neoadjuvant chemotherapy to allow more accurate assessment of pathologic response; patients must have a complete axillary lymph node dissection after neoadjuvant chemotherapy in the following situations (exceptions will be granted for patients participating in the Alliance A11202 trial):

    • Patients had documented pathologic involvement of the axillary nodes (fine needle aspiration [FNA] or core biopsy) before neoadjuvant chemotherapy and had sentinel node biopsy after neoadjuvant chemotherapy with positive sentinel node(s)
    • Patient had documented pathologic involvement of the axillary nodes (FNA or core biopsy) before neoadjuvant chemotherapy and had only 1 sentinel lymph node removed after neoadjuvant chemotherapy

      • NOTE: Patients who undergo sentinel node biopsy before starting neoadjuvant treatment and do not undergo post neoadjuvant assessment of the axillary nodes or who have negative axillary nodes on post neoadjuvant assessment must have >= 1 cm residual invasive cancer in the breast after completion of neoadjuvant chemotherapy
  • Patients must have a minimum of five, available unstained slides from the residual (post-neoadjuvant) invasive tumor in primary site or lymph node; (these will be submitted to determine PD-L1 expression) the tumor tissue must be adequate for PD-L1 testing, which typically requires a minimum of 100 cancer cells per slide

    • NOTE: Initial order for specimen kits should be placed at least two weeks prior to registering the first patient at each site
  • Patients must be offered the opportunity to participate in specimen banking
  • Patients must have had neoadjuvant chemotherapy followed by surgery; the recommended neoadjuvant treatment should include 16-24 weeks of a third generation chemotherapy regimen as recommended by National Comprehensive Cancer Network (NCCN) guidelines for triple negative breast cancer (examples include dose dense adriamycin-cytoxan [AC] followed by dose-dense paclitaxel; weekly paclitaxel x 12 followed or preceded by cyclophosphamide-adriamycin-fluorouracil [FAC], fluorouracil-epirubicin-cytoxan [FEC], AC or dose dense AC; docetaxel either followed or preceded by FEC/FAC or AC; carboplatin-containing neoadjuvant chemotherapy is also allowed); patients who cannot complete all planned treatment cycles for any reason are considered high risk and therefore are eligible for the study if they have residual disease; patients must have resolution of adverse event(s) of the most recent prior chemotherapy to grade 1 or less, except alopecia and =< grade 2 neuropathy which are allowed
  • Patients may receive post-operative (adjuvant) chemotherapy for up to 24 weeks of duration (e.g. 8 cycles of capecitabine as in the CREATE-X trial) after completion of surgery at the discretion of the treating physician; patients must have resolution of adverse event(s) of the most recent prior chemotherapy to grade 1 or less, except alopecia and =< grade 2 neuropathy which are allowed; patients that have received adjuvant chemotherapy must be registered to screening within 35 days after completing treatment
  • Patients must have completed their final breast surgery (rendering them free from disease) with clear resection margins for invasive cancer and DCIS within the following timelines:

    • 90 days prior to screening registration for patients not receiving post-operative (adjuvant) chemotherapy OR
    • 270 days prior to screening registration for patients who have received post-operative (adjuvant) chemotherapy Patients who receive postoperative chemotherapy may receive radiation therapy before or after the chemotherapy; a short course of reduced dose chemotherapy concomitant with radiation for radiation sensitization is not considered to be adjuvant chemotherapy; positive margins are allowed only if the surgical team of the patient deems further resection impossible
  • Patients for whom radiation therapy (RT) to the affected breast or chest wall and regional nodal areas is clinically indicated as per NCCN treatment guidelines, should receive RT after randomization when possible, and receive MK-3475 (pembrolizumab) concurrent with RT, if randomized to the experimental arm; however, RT administered, or initiated, prior to registration is also allowed; pembrolizumab may be added to ongoing radiation, or started after its completion, if randomized to the experimental arm, provided there are no > grade 2 radiation-related skin toxicities; patients who have not yet started radiation must specify at the time of screening registration whether or not they will receive RT and the extent of intended RT
  • Patients must not have had prior immunotherapy with anti-PD-L1, anti-PD-1, anti-CTLA4 or similar drugs; patients must not be planning to receive any of the prohibited therapies during the screening or treatment phases of the study
  • Patients must not be planning to receive concomitantly other biologic therapy, hormonal therapy, other chemotherapy, surgery or other anti-cancer therapy except radiation therapy while receiving treatment on this protocol; however, patients receiving extended adjuvant endocrine therapy for an earlier ER positive breast cancer treated with curative intent and without recurrence for at least 5 years may continue with their endocrine therapy
  • Patients must have Zubrod performance status =< 2
  • Patients must not have a history of (non-infectious) pneumonitis that required steroids or evidence of active pneumonitis
  • Patients must not have an active infection requiring systemic therapy
  • Patients must not have active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs); replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not considered a form of systemic treatment
  • Patients must not have received live vaccines within 30 days prior to registration; examples of live vaccines include, but are not limited to, the following: measles, mumps, rubella, chicken pox, shingles, yellow fever, rabies, Bacillus Calmette-Guerin (BCG), and typhoid (oral) vaccine; seasonal influenza vaccines for injection are generally killed virus vaccines and are allowed; however, intranasal influenza vaccines (e.g., Flu-Mist) are live attenuated vaccines, and are not allowed
  • Patients must not have known active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection prior to registration; patients who have completed curative therapy for HCV are eligible; patients with known human immunodeficiency virus (HIV) infection are eligible if they meet each of the following 3 criteria:

    • CD4 counts >= 350 mm^3
    • Serum HIV viral load of < 25,000 IU/ml and
    • Treated on a stable antiretroviral regimen
  • No other prior invasive malignancy is allowed except for the following: adequately treated basal (or squamous cell) skin cancer, in situ breast or cervical cancer; stage I or II invasive cancer treated with a curative intent without evidence of disease recurrence for at least five years
  • Patients must have complete history and physical examination within 28 days prior to registration
  • Patients must be informed of the investigational nature of this study and must sign and give written informed consent for this protocol in accordance with institutional and federal guidelines
  • As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
  • STEP 2 REGISTRATION
  • Patients must not be registered to step 2 until receiving confirmation from the Southwest Oncology Group (SWOG) Statistical Center that the patient's tissue specimen was adequate for PD-L1 testing; patients must be registered within 7 days of receiving the e-mail notification confirming submission was evaluable for PD-L1 status
  • Absolute neutrophil count (ANC) >= 1,500 microliter (mcL), obtained within 28 days prior to step 2 registration
  • Platelets >= 100,000/mcL, obtained within 28 days prior to step 2 registration
  • Hemoglobin >= 9 g/dL, obtained within 28 days prior to step 2 registration
  • A serum thyroid-stimulating hormone (TSH) must be obtained within 28 days prior to step 2 registration to obtain a baseline value
  • Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) (except Gilbert's syndrome, who must have a total bilirubin < 3.0 mg/dL), obtained within 28 days prior to step 2 registration
  • Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) or serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< 2.5 x IULN, obtained within 28 days prior to step 2 registration
  • Alkaline phosphatase =< 2.5 x IULN, obtained within 28 days prior to step 2 registration
  • Serum creatinine =< IULN OR measured or calculated creatinine clearance >= 60 mL/min, obtained within 28 days prior to step 2 registration
  • Women of childbearing potential must have a negative urine or serum pregnancy test within 28 day prior to registration; women/men of reproductive potential must have agreed to use an effective contraceptive method for the course of the study through 120 days after the last dose of study medication; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately; a woman is considered to be of "reproductive potential" if she has had menses at any time in the preceding 12 consecutive months; in addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy, bilateral tubal ligation, or vasectomy; however, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures; patients must not be pregnant or nursing
  • Site must verify that there is no known change in the step 1 eligibility since initial registration

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02954874


  Hide Study Locations
Locations
United States, Alabama
Southern Cancer Center PC-Daphne Recruiting
Daphne, Alabama, United States, 36526
Contact: Connie D. Uzel    251-607-5281    sue.deoliveira@southerncancercenter.com   
Principal Investigator: Connie D. Uzel         
Southern Cancer Center PC-Mobile Recruiting
Mobile, Alabama, United States, 36607
Contact: Connie D. Uzel    251-607-5281    sue.deoliveira@southerncancercenter.com   
Principal Investigator: Connie D. Uzel         
Southern Cancer Center PC-Providence Recruiting
Mobile, Alabama, United States, 36608
Contact: Connie D. Uzel    251-607-5281    sue.deoliveira@southerncancercenter.com   
Principal Investigator: Connie D. Uzel         
Southern Cancer Center PC-Springhill Recruiting
Mobile, Alabama, United States, 36608
Contact: Connie D. Uzel    251-607-5281    sue.deoliveira@southerncancercenter.com   
Principal Investigator: Connie D. Uzel         
University of South Alabama Mitchell Cancer Institute Recruiting
Mobile, Alabama, United States, 36688
Contact: Carole W. Norden    251-445-9870    pfrancisco@usouthal.edu   
Principal Investigator: Carole W. Norden         
United States, Alaska
Alaska Oncology and Hematology LLC Suspended
Anchorage, Alaska, United States, 99508
Anchorage Oncology Centre Suspended
Anchorage, Alaska, United States, 99508
Katmai Oncology Group Recruiting
Anchorage, Alaska, United States, 99508
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Providence Alaska Medical Center Suspended
Anchorage, Alaska, United States, 99508
Fairbanks Memorial Hospital Suspended
Fairbanks, Alaska, United States, 99701
United States, Arizona
University of Arizona Cancer Center-North Campus Recruiting
Tucson, Arizona, United States, 85719
Contact: Simran K. Sindhu    800-327-2873      
Principal Investigator: Simran K. Sindhu         
The University of Arizona Medical Center-University Campus Recruiting
Tucson, Arizona, United States, 85724
Contact: Simran K. Sindhu    520-626-9008      
Principal Investigator: Simran K. Sindhu         
United States, Arkansas
University of Arkansas for Medical Sciences Recruiting
Little Rock, Arkansas, United States, 72205
Contact: Issam Makhoul    501-686-8274      
Principal Investigator: Issam Makhoul         
Highlands Oncology Group-Rogers Recruiting
Rogers, Arkansas, United States, 72758
Contact: Joseph T. Beck    800-381-6939      
Principal Investigator: Joseph T. Beck         
United States, California
Kaiser Permanente-Anaheim Recruiting
Anaheim, California, United States, 92807
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
Kaiser Permanente-Deer Valley Medical Center Suspended
Antioch, California, United States, 94531
Sutter Auburn Faith Hospital Recruiting
Auburn, California, United States, 95602
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
AIS Cancer Center at San Joaquin Community Hospital Recruiting
Bakersfield, California, United States, 93301
Contact: Helen K. Chew    916-734-3089      
Principal Investigator: Helen K. Chew         
Kaiser Permanente-Baldwin Park Recruiting
Baldwin Park, California, United States, 91706
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
Kaiser Permanente-Bellflower Recruiting
Bellflower, California, United States, 90706
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
Alta Bates Summit Medical Center-Herrick Campus Recruiting
Berkeley, California, United States, 94704
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Mills-Peninsula Medical Center Suspended
Burlingame, California, United States, 94010
City of Hope Corona Recruiting
Corona, California, United States, 92879
Contact: Joanne E. Mortimer    800-826-4673    becomingapatient@coh.org   
Principal Investigator: Joanne E. Mortimer         
City of Hope Comprehensive Cancer Center Recruiting
Duarte, California, United States, 91010
Contact: Joanne E. Mortimer    800-826-4673    becomingapatient@coh.org   
Principal Investigator: Joanne E. Mortimer         
Epic Care-Dublin Recruiting
Dublin, California, United States, 94568
Contact: James H. Feusner       protocols@swog.org   
Principal Investigator: James H. Feusner         
Bay Area Breast Surgeons Inc Suspended
Emeryville, California, United States, 94608
Epic Care Partners in Cancer Care Recruiting
Emeryville, California, United States, 94608
Contact: James H. Feusner       protocols@swog.org   
Principal Investigator: James H. Feusner         
Kaiser Permanente-Fontana Recruiting
Fontana, California, United States, 92335
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
Kaiser Permanente-Fremont Suspended
Fremont, California, United States, 94538
Kaiser Permanente-Fresno Suspended
Fresno, California, United States, 93720
Saint Jude Medical Center Suspended
Fullerton, California, United States, 92835
Kaiser Permanente - Harbor City Recruiting
Harbor City, California, United States, 90710
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
Kaiser Permanente-Irvine Recruiting
Irvine, California, United States, 92618
Contact: Jonathan A. Polikoff    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Jonathan A. Polikoff         
Kaiser Permanente Los Angeles Medical Center Recruiting
Los Angeles, California, United States, 90027
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
Los Angeles County-USC Medical Center Recruiting
Los Angeles, California, United States, 90033
Contact: Min J. Lu    323-865-0451      
Principal Investigator: Min J. Lu         
USC / Norris Comprehensive Cancer Center Recruiting
Los Angeles, California, United States, 90033
Contact: Min J. Lu    323-865-0451      
Principal Investigator: Min J. Lu         
Kaiser Permanente-Cadillac Recruiting
Los Angeles, California, United States, 90034
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
Contra Costa Regional Medical Center Recruiting
Martinez, California, United States, 94553-3156
Contact: James H. Feusner       protocols@swog.org   
Principal Investigator: James H. Feusner         
Fremont - Rideout Cancer Center Recruiting
Marysville, California, United States, 95901
Contact: Site Public Contact    530-749-4400      
Principal Investigator: Helen K. Chew         
Memorial Medical Center Suspended
Modesto, California, United States, 95355
Kaiser Permanente-Modesto Suspended
Modesto, California, United States, 95356
Palo Alto Medical Foundation-Camino Division Recruiting
Mountain View, California, United States, 94040
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Palo Alto Medical Foundation-Gynecologic Oncology Suspended
Mountain View, California, United States, 94040
USC Norris Oncology/Hematology-Newport Beach Suspended
Newport Beach, California, United States, 92663
Sutter Cancer Research Consortium Suspended
Novato, California, United States, 94945
Alta Bates Summit Medical Center - Summit Campus Suspended
Oakland, California, United States, 94609
Bay Area Tumor Institute Suspended
Oakland, California, United States, 94609
Kaiser Permanente-Oakland Recruiting
Oakland, California, United States, 94611
Contact: Jennifer M. Suga    510-891-3400      
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-Ontario Suspended
Ontario, California, United States, 91761
Saint Joseph Hospital - Orange Recruiting
Orange, California, United States, 92868
Contact: Timothy E. Byun    714-734-6220      
Principal Investigator: Timothy E. Byun         
UC Irvine Health/Chao Family Comprehensive Cancer Center Suspended
Orange, California, United States, 92868
Palo Alto Medical Foundation Health Care Recruiting
Palo Alto, California, United States, 94301
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Stanford Cancer Institute Palo Alto Recruiting
Palo Alto, California, United States, 94304
Contact: Melinda L. Telli    650-498-7061    ccto-office@stanford.edu   
Principal Investigator: Melinda L. Telli         
Kaiser Permanente - Panorama City Recruiting
Panorama City, California, United States, 91402
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
Huntington Memorial Hospital Recruiting
Pasadena, California, United States, 91105
Contact: Steven H. Applebaum    626-535-2420      
Principal Investigator: Steven H. Applebaum         
Kaiser Permanente-Redwood City Suspended
Redwood City, California, United States, 94063
Kaiser Permanente-Richmond Suspended
Richmond, California, United States, 94801
Kaiser Permanente-Riverside Recruiting
Riverside, California, United States, 92505
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
Kaiser Permanente-Roseville Recruiting
Roseville, California, United States, 95661
Contact: Jennifer M. Suga    510-891-3400      
Principal Investigator: Jennifer M. Suga         
Sutter Roseville Medical Center Recruiting
Roseville, California, United States, 95661
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Sutter Medical Center Sacramento Recruiting
Sacramento, California, United States, 95816
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
University of California Davis Comprehensive Cancer Center Recruiting
Sacramento, California, United States, 95817
Contact: Helen K. Chew    916-734-3089      
Principal Investigator: Helen K. Chew         
Kaiser Permanente - Sacramento Recruiting
Sacramento, California, United States, 95825
Contact: Jennifer M. Suga    510-891-3400      
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-San Diego Mission Suspended
San Diego, California, United States, 92108
Kaiser Permanente-San Diego Zion Recruiting
San Diego, California, United States, 92120
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
California Pacific Medical Center-Pacific Campus Recruiting
San Francisco, California, United States, 94115
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Kaiser Permanente-San Francisco Recruiting
San Francisco, California, United States, 94115
Contact: Jennifer M. Suga    510-891-3400      
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-Santa Teresa-San Jose Recruiting
San Jose, California, United States, 95119
Contact: Jennifer M. Suga    510-891-3400      
Principal Investigator: Jennifer M. Suga         
Stanford Cancer Center South Bay Suspended
San Jose, California, United States, 95124
Kaiser Permanente San Leandro Recruiting
San Leandro, California, United States, 94577
Contact: Jennifer M. Suga    510-454-2724      
Principal Investigator: Jennifer M. Suga         
Pacific Central Coast Health Center-San Luis Obispo Active, not recruiting
San Luis Obispo, California, United States, 93401
Kaiser Permanente-San Marcos Recruiting
San Marcos, California, United States, 92078
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
Kaiser Permanente Medical Center - Santa Clara Recruiting
Santa Clara, California, United States, 95051
Contact: Jennifer M. Suga    510-891-3400      
Principal Investigator: Jennifer M. Suga         
Palo Alto Medical Foundation-Santa Cruz Recruiting
Santa Cruz, California, United States, 95065
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Kaiser Permanente-Santa Rosa Suspended
Santa Rosa, California, United States, 95403
Kaiser Permanente-South San Francisco Recruiting
South San Francisco, California, United States, 94080
Contact: Jennifer M. Suga    510-891-3400      
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-Stockton Suspended
Stockton, California, United States, 95210
Palo Alto Medical Foundation-Sunnyvale Recruiting
Sunnyvale, California, United States, 94086
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Gene Upshaw Memorial Tahoe Forest Cancer Center Recruiting
Truckee, California, United States, 96161
Contact: Helen K. Chew    916-734-3089      
Principal Investigator: Helen K. Chew         
Kaiser Permanente Medical Center-Vacaville Suspended
Vacaville, California, United States, 95688
Kaiser Permanente-Vallejo Recruiting
Vallejo, California, United States, 94589
Contact: Jennifer M. Suga    510-891-3400      
Principal Investigator: Jennifer M. Suga         
Sutter Solano Medical Center/Cancer Center Suspended
Vallejo, California, United States, 94589
Kaiser Permanente-Walnut Creek Recruiting
Walnut Creek, California, United States, 94596
Contact: Jennifer M. Suga    510-891-3400      
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-Woodland Hills Recruiting
Woodland Hills, California, United States, 91367
Contact: Jonathan A. Polikoff    626-564-3455      
Principal Investigator: Jonathan A. Polikoff         
United States, Colorado
University of Colorado Hospital Recruiting
Aurora, Colorado, United States, 80045
Contact: Anthony D. Elias    720-848-0650      
Principal Investigator: Anthony D. Elias         
Rocky Mountain Cancer Centers-Boulder Recruiting
Boulder, Colorado, United States, 80304
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Penrose-Saint Francis Healthcare Recruiting
Colorado Springs, Colorado, United States, 80907
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
UCHealth Memorial Hospital Central Recruiting
Colorado Springs, Colorado, United States, 80909
Contact: Anthony D. Elias    719-365-2406      
Principal Investigator: Anthony D. Elias         
Kaiser Permanente-Franklin Recruiting
Denver, Colorado, United States, 80205
Contact: Alexander Menter    303-614-1300      
Principal Investigator: Alexander Menter         
National Jewish Health-Main Campus Recruiting
Denver, Colorado, United States, 80206
Contact: Keren Sturtz    877-225-5654    glicht@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Porter Adventist Hospital Suspended
Denver, Colorado, United States, 80210
Comprehensive Cancer Care and Research Institute of Colorado LLC Recruiting
Englewood, Colorado, United States, 80113
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Poudre Valley Hospital Recruiting
Fort Collins, Colorado, United States, 80524
Contact: Anthony D. Elias    970-297-6150      
Principal Investigator: Anthony D. Elias         
National Jewish Health-Western Hematology Oncology Recruiting
Golden, Colorado, United States, 80401
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
North Colorado Medical Center Recruiting
Greeley, Colorado, United States, 80631
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Kaiser Permanente-Rock Creek Recruiting
Lafayette, Colorado, United States, 80026
Contact: Alexander Menter    303-614-1300      
Principal Investigator: Alexander Menter         
Saint Anthony Hospital Suspended
Lakewood, Colorado, United States, 80228
Littleton Adventist Hospital Suspended
Littleton, Colorado, United States, 80122
Kaiser Permanente-Lone Tree Recruiting
Lone Tree, Colorado, United States, 80124
Contact: Alexander Menter    303-614-1300      
Principal Investigator: Alexander Menter         
Longmont United Hospital Recruiting
Longmont, Colorado, United States, 80501
Contact: Mehmet S. Copur    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Mehmet S. Copur         
McKee Medical Center Recruiting
Loveland, Colorado, United States, 80539
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Parker Adventist Hospital Suspended
Parker, Colorado, United States, 80138
National Jewish Health-Northern Hematology Oncology Recruiting
Thornton, Colorado, United States, 80260
Contact: Keren Sturtz    303-777-2663    glicht@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
SCL Health Lutheran Medical Center Recruiting
Wheat Ridge, Colorado, United States, 80033
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
United States, Connecticut
Smilow Cancer Hospital-Derby Care Center Suspended
Derby, Connecticut, United States, 06418
Greenwich Hospital Recruiting
Greenwich, Connecticut, United States, 06830
Contact: Beverly J. Drucker    203-863-3698      
Principal Investigator: Beverly J. Drucker         
Smilow Cancer Hospital Care Center at Saint Francis Suspended
Hartford, Connecticut, United States, 06105
Smilow Cancer Center/Yale-New Haven Hospital Suspended
New Haven, Connecticut, United States, 06510
Yale University Suspended
New Haven, Connecticut, United States, 06520
Yale-New Haven Hospital North Haven Medical Center Suspended
North Haven, Connecticut, United States, 06473
Smilow Cancer Hospital-Orange Care Center Suspended
Orange, Connecticut, United States, 06477
Smilow Cancer Hospital-Torrington Care Center Suspended
Torrington, Connecticut, United States, 06790
Smilow Cancer Hospital Care Center-Trumbull Suspended
Trumbull, Connecticut, United States, 06611
Smilow Cancer Hospital-Waterbury Care Center Suspended
Waterbury, Connecticut, United States, 06708
United States, Delaware
Helen F Graham Cancer Center Suspended
Newark, Delaware, United States, 19713
Medical Oncology Hematology Consultants PA Suspended
Newark, Delaware, United States, 19713
Beebe Health Campus Suspended
Rehoboth Beach, Delaware, United States, 19971
Nanticoke Memorial Hospital Suspended
Seaford, Delaware, United States, 19973
United States, District of Columbia
Sibley Memorial Hospital Suspended
Washington, District of Columbia, United States, 20016
United States, Florida
Baptist MD Anderson Cancer Center Recruiting
Jacksonville, Florida, United States, 32207
Contact: Site Public Contact    904-202-7051      
Principal Investigator: Jennifer A. Crozier         
UF Cancer Center at Orlando Health Recruiting
Orlando, Florida, United States, 32806
Contact: Regan D. Rostorfer    321-841-7246    CancerClinicalTrials@orlandohealth.com   
Principal Investigator: Regan D. Rostorfer         
Sacred Heart Hospital Recruiting
Pensacola, Florida, United States, 32504
Contact: Ranjith B. Dissanayake    850-416-4611    ttamayo@shhpens.org   
Principal Investigator: Ranjith B. Dissanayake         
Cleveland Clinic-Weston Recruiting
Weston, Florida, United States, 33331
Contact: Aaron T. Gerds    954-659-5705    CancerAnswer@ccf.org   
Principal Investigator: Aaron T. Gerds         
United States, Georgia
Phoebe Putney Memorial Hospital Recruiting
Albany, Georgia, United States, 31701
Contact: Sharad A. Ghamande    229-312-0405    ga_cares@augusta.edu   
Principal Investigator: Sharad A. Ghamande         
Northside Hospital Recruiting
Atlanta, Georgia, United States, 30342
Contact: Amelia B. Zelnak    404-303-3355    ClinicalTrials@northside.com   
Principal Investigator: Amelia B. Zelnak         
Dekalb Medical Center Recruiting
Decatur, Georgia, United States, 30033
Contact: Sharad A. Ghamande    706-721-1663    cancer@augusta.edu   
Principal Investigator: Sharad A. Ghamande         
Gwinnett Medical Center Recruiting
Lawrenceville, Georgia, United States, 30046
Contact: Aldemar Montero    678-312-2666      
Principal Investigator: Aldemar Montero         
Memorial Health University Medical Center Recruiting
Savannah, Georgia, United States, 31404
Contact: Christopher E. Haberman    912-350-7887    clayter1@memorialhealth.com   
Principal Investigator: Christopher E. Haberman         
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Recruiting
Savannah, Georgia, United States, 31405
Contact: Howard A. Zaren    912-819-5704      
Principal Investigator: Howard A. Zaren         
South Georgia Medical Center/Pearlman Cancer Center Recruiting
Valdosta, Georgia, United States, 31602
Contact: Samuel N. Ofori    229-259-4628    maryann.heddon@sgmc.org   
Principal Investigator: Samuel N. Ofori         
United States, Idaho
Saint Alphonsus Cancer Care Center-Boise Recruiting
Boise, Idaho, United States, 83706
Contact: Christopher M. Reynolds    734-712-3671      
Principal Investigator: Christopher M. Reynolds         
Saint Luke's Mountain States Tumor Institute Recruiting
Boise, Idaho, United States, 83712
Contact: Gary E. Goodman       protocols@swog.org   
Principal Investigator: Gary E. Goodman         
Saint Alphonsus Cancer Care Center-Caldwell Recruiting
Caldwell, Idaho, United States, 83605
Contact: Christopher M. Reynolds    734-712-3671      
Principal Investigator: Christopher M. Reynolds         
Kootenai Medical Center Suspended
Coeur d'Alene, Idaho, United States, 83814
Walter Knox Memorial Hospital Suspended
Emmett, Idaho, United States, 83617
Saint Luke's Mountain States Tumor Institute - Fruitland Recruiting
Fruitland, Idaho, United States, 83619
Contact: Gary E. Goodman       protocols@swog.org   
Principal Investigator: Gary E. Goodman         
Idaho Urologic Institute-Meridian Suspended
Meridian, Idaho, United States, 83642
Saint Luke's Mountain States Tumor Institute - Meridian Recruiting
Meridian, Idaho, United States, 83642
Contact: Gary E. Goodman       protocols@swog.org   
Principal Investigator: Gary E. Goodman         
Saint Alphonsus Medical Center-Nampa Recruiting
Nampa, Idaho, United States, 83686
Contact: Christopher M. Reynolds    734-712-3671      
Principal Investigator: Christopher M. Reynolds         
Saint Luke's Mountain States Tumor Institute - Nampa Recruiting
Nampa, Idaho, United States, 83686
Contact: Gary E. Goodman       protocols@swog.org   
Principal Investigator: Gary E. Goodman         
Kootenai Cancer Center Suspended
Post Falls, Idaho, United States, 83854
Kootenai Cancer Clinic Suspended
Sandpoint, Idaho, United States, 83864
Saint Luke's Mountain States Tumor Institute-Twin Falls Recruiting
Twin Falls, Idaho, United States, 83301
Contact: Gary E. Goodman       protocols@swog.org   
Principal Investigator: Gary E. Goodman         
United States, Illinois
Rush - Copley Medical Center Recruiting
Aurora, Illinois, United States, 60504
Contact: Kendrith M. Rowland    630-978-6212    Cancer.Research@rushcopley.com   
Principal Investigator: Kendrith M. Rowland         
Mac Neal Hospital Active, not recruiting
Berwyn, Illinois, United States, 60402
Illinois CancerCare-Bloomington Recruiting
Bloomington, Illinois, United States, 61704
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Canton Recruiting
Canton, Illinois, United States, 61520
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Carthage Recruiting
Carthage, Illinois, United States, 62321
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Centralia Oncology Clinic Suspended
Centralia, Illinois, United States, 62801
Mount Sinai Hospital Medical Center Recruiting
Chicago, Illinois, United States, 60608
Contact: Pam G. Khosla    773-257-5960    suhi@sinai.org   
Principal Investigator: Pam G. Khosla         
Northwestern University Recruiting
Chicago, Illinois, United States, 60611
Contact: William J. Gradishar    312-695-1301    cancer@northwestern.edu   
Principal Investigator: William J. Gradishar         
Rush University Medical Center Recruiting
Chicago, Illinois, United States, 60612
Contact: Melody A. Cobleigh    312-942-5498    clinical_trials@rush.edu   
Principal Investigator: Melody A. Cobleigh         
University of Illinois Recruiting
Chicago, Illinois, United States, 60612
Contact: Oana C. Danciu    312-355-3046      
Principal Investigator: Oana C. Danciu         
University of Chicago Comprehensive Cancer Center Recruiting
Chicago, Illinois, United States, 60637
Contact: Rita Nanda    773-834-7424      
Principal Investigator: Rita Nanda         
Weiss Memorial Hospital Recruiting
Chicago, Illinois, United States, 60640
Contact: Stuart A. Krauss    773-564-5032      
Principal Investigator: Stuart A. Krauss         
Cancer Care Specialists of Central Illinois Recruiting
Decatur, Illinois, United States, 62526
Contact: Bryan A. Faller    217-876-4740    rhamrick@dmhhs.org   
Principal Investigator: Bryan A. Faller         
Decatur Memorial Hospital Suspended
Decatur, Illinois, United States, 62526
Northwestern Medicine Cancer Center Kishwaukee Suspended
DeKalb, Illinois, United States, 60115
Crossroads Cancer Center Recruiting
Effingham, Illinois, United States, 62401
Contact: Bryan A. Faller    217-876-4740    rhamrick@dmhhs.org   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Eureka Recruiting
Eureka, Illinois, United States, 61530
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Galesburg Recruiting
Galesburg, Illinois, United States, 61401
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Northwestern Medicine Cancer Center Delnor Recruiting
Geneva, Illinois, United States, 60134
Contact: John D. Ayers    847-827-9060      
Principal Investigator: John D. Ayers         
Joliet Oncology-Hematology Associates Limited Recruiting
Joliet, Illinois, United States, 60435
Contact: Site Public Contact    815-730-3098    maureenc@jolietoncology.com   
Principal Investigator: Nafisa D. Burhani         
Presence Saint Mary's Hospital Suspended
Kankakee, Illinois, United States, 60901
Illinois CancerCare-Kewanee Clinic Recruiting
Kewanee, Illinois, United States, 61443
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Northwestern Medicine Lake Forest Hospital Recruiting
Lake Forest, Illinois, United States, 60045
Contact: William J. Gradishar    312-695-1301    cancer@northwestern.edu   
Principal Investigator: William J. Gradishar         
Illinois CancerCare-Macomb Recruiting
Macomb, Illinois, United States, 61455
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Loyola University Medical Center Recruiting
Maywood, Illinois, United States, 60153
Contact: Kathy S. Albain    708-226-4357      
Principal Investigator: Kathy S. Albain         
Illinois CancerCare-Ottawa Clinic Recruiting
Ottawa, Illinois, United States, 61350
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Pekin Recruiting
Pekin, Illinois, United States, 61554
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Peoria Recruiting
Peoria, Illinois, United States, 61615
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Peru Recruiting
Peru, Illinois, United States, 61354
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Princeton Recruiting
Princeton, Illinois, United States, 61356
Contact: Bryan A. Faller    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
West Suburban Medical Center Recruiting
River Forest, Illinois, United States, 60305
Contact: Site Public Contact    708-763-2707      
Principal Investigator: Isoken Koko         
SwedishAmerican Regional Cancer Center/ACT Recruiting
Rockford, Illinois, United States, 61114
Contact: Site Public Contact    779-696-9400    cancercare@swedishamerican.org   
Principal Investigator: Harvey E. Einhorn         
Southern Illinois University School of Medicine Recruiting
Springfield, Illinois, United States, 62702
Contact: Bryan A. Faller    217-545-7929      
Principal Investigator: Bryan A. Faller         
Springfield Clinic Recruiting
Springfield, Illinois, United States, 62702
Contact: Bryan A. Faller    800-444-7541      
Principal Investigator: Bryan A. Faller         
Memorial Medical Center Suspended
Springfield, Illinois, United States, 62781
Cancer Care Specialists of Illinois-Swansea Suspended
Swansea, Illinois, United States, 62226
Northwestern Medicine Cancer Center Warrenville Recruiting
Warrenville, Illinois, United States, 60555
Contact: John D. Ayers    847-827-9060      
Principal Investigator: John D. Ayers         
Rush-Copley Healthcare Center Recruiting
Yorkville, Illinois, United States, 60560
Contact: Kendrith M. Rowland    630-978-6212    Cancer.Research@rushcopley.com   
Principal Investigator: Kendrith M. Rowland         
United States, Indiana
Deaconess Clinic Downtown Recruiting
Evansville, Indiana, United States, 47713
Contact: Kendrith M. Rowland    877-654-0311      
Principal Investigator: Kendrith M. Rowland         
Indiana University/Melvin and Bren Simon Cancer Center Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Site Public Contact    317-278-5632    iutrials@iu.edu   
Principal Investigator: Tarah J. Ballinger         
Memorial Regional Cancer Center Day Road Suspended
Mishawaka, Indiana, United States, 46545
Chancellor Center for Oncology Recruiting
Newburgh, Indiana, United States, 47630
Contact: Kendrith M. Rowland    812-426-9576      
Principal Investigator: Kendrith M. Rowland         
Memorial Hospital of South Bend Recruiting
South Bend, Indiana, United States, 46601
Contact: Thomas J. Reid    800-284-7370      
Principal Investigator: Thomas J. Reid         
United States, Iowa
Mary Greeley Medical Center Recruiting
Ames, Iowa, United States, 50010
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
McFarland Clinic PC - Ames Recruiting
Ames, Iowa, United States, 50010
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
McFarland Clinic PC-Boone Recruiting
Boone, Iowa, United States, 50036
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
Medical Oncology and Hematology Associates-West Des Moines Recruiting
Clive, Iowa, United States, 50325
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Mercy Cancer Center-West Lakes Recruiting
Clive, Iowa, United States, 50325
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Greater Regional Medical Center Suspended
Creston, Iowa, United States, 50801
Genesis Medical Center - East Campus Recruiting
Davenport, Iowa, United States, 52803
Contact: George Kovach    800-446-6088    werners@genesishealth.com   
Principal Investigator: George Kovach         
Iowa Methodist Medical Center Recruiting
Des Moines, Iowa, United States, 50309
Contact: Robert J. Behrens    515-239-2621      
Principal Investigator: Robert J. Behrens         
Medical Oncology and Hematology Associates-Des Moines Recruiting
Des Moines, Iowa, United States, 50309
Contact: Robert J. Behrens    515-239-2621      
Principal Investigator: Robert J. Behrens         
Broadlawns Medical Center Recruiting
Des Moines, Iowa, United States, 50314
Contact: Robert J. Behrens    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Robert J. Behrens         
Medical Oncology and Hematology Associates-Laurel Recruiting
Des Moines, Iowa, United States, 50314
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Mercy Medical Center - Des Moines Recruiting
Des Moines, Iowa, United States, 50314
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Iowa Lutheran Hospital Suspended
Des Moines, Iowa, United States, 50316
McFarland Clinic PC-Trinity Cancer Center Recruiting
Fort Dodge, Iowa, United States, 50501
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
McFarland Clinic PC-Jefferson Recruiting
Jefferson, Iowa, United States, 50129
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
McFarland Clinic PC-Marshalltown Recruiting
Marshalltown, Iowa, United States, 50158
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
Methodist West Hospital Suspended
West Des Moines, Iowa, United States, 50266-7700
Mercy Medical Center-West Lakes Recruiting
West Des Moines, Iowa, United States, 50266
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
United States, Kansas
Cancer Center of Kansas - Chanute Active, not recruiting
Chanute, Kansas, United States, 66720
Cancer Center of Kansas - Dodge City Active, not recruiting
Dodge City, Kansas, United States, 67801
Cancer Center of Kansas - Fort Scott Active, not recruiting
Fort Scott, Kansas, United States, 66701
Central Care Cancer Center - Garden City Recruiting
Garden City, Kansas, United States, 67846
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Central Care Cancer Center - Great Bend Suspended
Great Bend, Kansas, United States, 67530
University of Kansas Cancer Center Recruiting
Kansas City, Kansas, United States, 66160
Contact: Joshua M. Mammen    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Joshua M. Mammen         
Cancer Center of Kansas-Kingman Active, not recruiting
Kingman, Kansas, United States, 67068
Lawrence Memorial Hospital Recruiting
Lawrence, Kansas, United States, 66044
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Kansas Institute of Medicine Cancer and Blood Center Recruiting
Lenexa, Kansas, United States, 66219
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Minimally Invasive Surgery Hospital Suspended
Lenexa, Kansas, United States, 66219
Cancer Center of Kansas-Liberal Active, not recruiting
Liberal, Kansas, United States, 67905
Cancer Center of Kansas - McPherson Active, not recruiting
McPherson, Kansas, United States, 67460
Cancer Center of Kansas - Newton Active, not recruiting
Newton, Kansas, United States, 67114
Olathe Medical Center Recruiting
Olathe, Kansas, United States, 66061
Contact: Site Public Contact    913-791-3500    Jeni.wakefield@olathehealth.org   
Principal Investigator: Joshua M. Mammen         
Menorah Medical Center Suspended
Overland Park, Kansas, United States, 66209
Cancer Center of Kansas - Parsons Active, not recruiting
Parsons, Kansas, United States, 67357
Via Christi Hospital-Pittsburg Recruiting
Pittsburg, Kansas, United States, 66762
Contact: Site Public Contact    620-235-7900      
Principal Investigator: Joshua M. Mammen         
Cancer Center of Kansas - Pratt Active, not recruiting
Pratt, Kansas, United States, 67124
Salina Regional Health Center Recruiting
Salina, Kansas, United States, 67401
Contact: Site Public Contact    785-452-7038    kkavoura@srhc.com   
Principal Investigator: Joshua M. Mammen         
Saint Francis Hospital and Medical Center - Topeka Recruiting
Topeka, Kansas, United States, 66606
Contact: Site Public Contact    785-295-8000      
Principal Investigator: Joshua M. Mammen         
Cancer Center of Kansas - Wellington Active, not recruiting
Wellington, Kansas, United States, 67152
University of Kansas Hospital-Westwood Cancer Center Recruiting
Westwood, Kansas, United States, 66205
Contact: Joshua M. Mammen    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Joshua M. Mammen         
Cancer Center of Kansas-Wichita Medical Arts Tower Recruiting
Wichita, Kansas, United States, 67208
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Wichita Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-268-5374    Keisha.humphries@ascension.org   
Principal Investigator: Shaker R. Dakhil         
Via Christi Regional Medical Center Active, not recruiting
Wichita, Kansas, United States, 67214
Cancer Center of Kansas - Winfield Active, not recruiting
Winfield, Kansas, United States, 67156
United States, Kentucky
Baptist Health Lexington Recruiting
Lexington, Kentucky, United States, 40503
Contact: Amy Schell    859-260-6425      
Principal Investigator: Amy Schell         
Saint Joseph Hospital East Recruiting
Lexington, Kentucky, United States, 40509
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
University of Kentucky/Markey Cancer Center Recruiting
Lexington, Kentucky, United States, 40536
Contact: Mara D. Chambers    859-257-3379      
Principal Investigator: Mara D. Chambers         
United States, Louisiana
Christus Saint Frances Cabrini Hospital Recruiting
Alexandria, Louisiana, United States, 71301
Contact: John T. Cole    504-842-3708      
Principal Investigator: John T. Cole         
LSU Health Baton Rouge-North Clinic Recruiting
Baton Rouge, Louisiana, United States, 70805
Contact: David S. Hanson    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Hematology/Oncology Clinic LLP Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: Hana F. Safah    504-988-6121      
Principal Investigator: Hana F. Safah         
Louisiana Hematology Oncology Associates LLC Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: David S. Hanson    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Mary Bird Perkins Cancer Center Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: David S. Hanson    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Ochsner Health Center-Summa Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: John T. Cole    504-842-3708      
Principal Investigator: John T. Cole         
Our Lady of the Lake Physicians Group - Medical Oncology Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: David S. Hanson    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Medical Center of Baton Rouge Recruiting
Baton Rouge, Louisiana, United States, 70816
Contact: John T. Cole    225-761-5346    Camille.Beck@Ochsner.org   
Principal Investigator: John T. Cole         
Northshore Oncology Associates-Covington Recruiting
Covington, Louisiana, United States, 70433
Contact: David S. Hanson    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Oncology Center of The South Incorporated Recruiting
Houma, Louisiana, United States, 70360
Contact: Site Public Contact    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Ochsner Medical Center Kenner Recruiting
Kenner, Louisiana, United States, 70065
Contact: John T. Cole    504-842-3708      
Principal Investigator: John T. Cole         
CHRISTUS Saint Patrick Hospital Suspended
Lake Charles, Louisiana, United States, 70601
Ochsner Medical Center Jefferson Recruiting
New Orleans, Louisiana, United States, 70121
Contact: John T. Cole    504-842-3708      
Principal Investigator: John T. Cole         
United States, Maine
Eastern Maine Medical Center Suspended
Bangor, Maine, United States, 04401
Lafayette Family Cancer Center-EMMC Recruiting
Brewer, Maine, United States, 04412
Contact: Thomas H. Openshaw    800-987-3005      
Principal Investigator: Thomas H. Openshaw         
York Hospital Recruiting
York, Maine, United States, 03909
Contact: Marilyn A. McLaughlin    207-351-3777      
Principal Investigator: Marilyn A. McLaughlin         
United States, Maryland
Mercy Medical Center Suspended
Baltimore, Maryland, United States, 21202
Greater Baltimore Medical Center Suspended
Baltimore, Maryland, United States, 21204
Saint Agnes Hospital Suspended
Baltimore, Maryland, United States, 21229
Johns Hopkins University/Sidney Kimmel Cancer Center Suspended
Baltimore, Maryland, United States, 21287
Upper Chesapeake Medical Center Recruiting
Bel Air, Maryland, United States, 21014
Contact: Ashkan Bahrani    443-643-3010      
Principal Investigator: Ashkan Bahrani         
Frederick Memorial Hospital Recruiting
Frederick, Maryland, United States, 21701
Contact: Brian M. O'Connor    240-566-3584    clinicaltrials@fmh.org   
Principal Investigator: Brian M. O'Connor         
University of Maryland Saint Joseph Medical Center Recruiting
Towson, Maryland, United States, 21204
Contact: Rima J. Couzi    410-337-4569    patriciajohnson@catholichealth.net   
Principal Investigator: Rima J. Couzi         
United States, Massachusetts
Boston Medical Center Suspended
Boston, Massachusetts, United States, 02118
Lahey Hospital and Medical Center Recruiting
Burlington, Massachusetts, United States, 01805
Contact: Corrine L. Zarwan    781-744-8027      
Principal Investigator: Corrine L. Zarwan         
Lowell General Hospital Recruiting
Lowell, Massachusetts, United States, 01854
Contact: Richard M. Zuniga    978-788-7084    ghincks@lowellgeneral.org   
Principal Investigator: Richard M. Zuniga         
Baystate Medical Center Recruiting
Springfield, Massachusetts, United States, 01199
Contact: Grace Makari-Judson    413-794-3565    tamara.wrenn@baystatehealth.org   
Principal Investigator: Grace Makari-Judson         
United States, Michigan
Saint Joseph Mercy Hospital Recruiting
Ann Arbor, Michigan, United States, 48106
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
University of Michigan Comprehensive Cancer Center Recruiting
Ann Arbor, Michigan, United States, 48109
Contact: Anne F. Schott    800-865-1125      
Principal Investigator: Anne F. Schott         
Bronson Battle Creek Recruiting
Battle Creek, Michigan, United States, 49017
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
IHA Hematology Oncology Consultants-Brighton Recruiting
Brighton, Michigan, United States, 48114
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Henry Ford Cancer Institute¿Downriver Recruiting
Brownstown, Michigan, United States, 48183
Contact: Ding Wang    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Ding Wang         
Caro Cancer Center Suspended
Caro, Michigan, United States, 48723
IHA Hematology Oncology Consultants-Chelsea Recruiting
Chelsea, Michigan, United States, 48118
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Hematology Oncology Consultants-Clarkston Recruiting
Clarkston, Michigan, United States, 48346
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Newland Medical Associates-Clarkston Recruiting
Clarkston, Michigan, United States, 48346
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Henry Ford Macomb Hospital-Clinton Township Recruiting
Clinton Township, Michigan, United States, 48038
Contact: Ding Wang    313-916-1784      
Principal Investigator: Ding Wang         
Henry Ford Medical Center-Fairlane Recruiting
Dearborn, Michigan, United States, 48126
Contact: Ding Wang    888-734-5322      
Principal Investigator: Ding Wang         
Henry Ford Hospital Recruiting
Detroit, Michigan, United States, 48202
Contact: Ding Wang    313-916-1784      
Principal Investigator: Ding Wang         
Saint John Hospital and Medical Center Suspended
Detroit, Michigan, United States, 48236
Michigan State University Clinical Center Recruiting
East Lansing, Michigan, United States, 48824-7016
Contact: Deimante M. Tamkus    517-975-9547      
Principal Investigator: Deimante M. Tamkus         
Genesee Cancer and Blood Disease Treatment Center Recruiting
Flint, Michigan, United States, 48503
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Genesee Hematology Oncology PC Recruiting
Flint, Michigan, United States, 48503
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Genesys Hurley Cancer Institute Recruiting
Flint, Michigan, United States, 48503
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Hurley Medical Center Recruiting
Flint, Michigan, United States, 48503
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Mercy Health Saint Mary's Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Kathleen J. Yost       protocols@swog.org   
Principal Investigator: Kathleen J. Yost         
Spectrum Health at Butterworth Campus Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center Suspended
Grosse Pointe Woods, Michigan, United States, 48236
West Michigan Cancer Center Recruiting
Kalamazoo, Michigan, United States, 49007
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Sparrow Hospital Suspended
Lansing, Michigan, United States, 48912
Saint Mary Mercy Hospital Suspended
Livonia, Michigan, United States, 48154
Great Lakes Cancer Management Specialists-Macomb Medical Campus Suspended
Macomb, Michigan, United States, 48044
Saint Mary's Oncology/Hematology Associates of Marlette Suspended
Marlette, Michigan, United States, 48453
Mid-Michigan Medical Center - Midland Recruiting
Midland, Michigan, United States, 48670
Contact: Michel R. Hurtubise    989-839-3377      
Principal Investigator: Michel R. Hurtubise         
Monroe Cancer Center Active, not recruiting
Monroe, Michigan, United States, 48162
Mercy Health Mercy Campus Recruiting
Muskegon, Michigan, United States, 49444
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Assarian Cancer Center Suspended
Novi, Michigan, United States, 48374-1236
Henry Ford Medical Center-Columbus Recruiting
Novi, Michigan, United States, 48377
Contact: Ding Wang    888-734-5322      
Principal Investigator: Ding Wang         
21st Century Oncology-Pontiac Suspended
Pontiac, Michigan, United States, 48341
Hope Cancer Center Suspended
Pontiac, Michigan, United States, 48341
Newland Medical Associates-Pontiac Recruiting
Pontiac, Michigan, United States, 48341
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Saint Joseph Mercy Oakland Recruiting
Pontiac, Michigan, United States, 48341
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Spectrum Health Reed City Hospital Recruiting
Reed City, Michigan, United States, 49677
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Saint Mary's of Michigan Recruiting
Saginaw, Michigan, United States, 48601
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Oncology Hematology Associates of Saginaw Valley PC Recruiting
Saginaw, Michigan, United States, 48604
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Marie Yeager Cancer Center Recruiting
Saint Joseph, Michigan, United States, 49085
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Providence Hospital-Southfield Cancer Center Recruiting
Southfield, Michigan, United States, 48075
Contact: Cynthia M. Vakhariya    248-849-5337    jaswinder.grewal@stjohn.org   
Principal Investigator: Cynthia M. Vakhariya         
Munson Medical Center Recruiting
Traverse City, Michigan, United States, 49684
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Great Lakes Cancer Management Specialists-Macomb Professional Building Suspended
Warren, Michigan, United States, 48093
Saint John Macomb-Oakland Hospital Suspended
Warren, Michigan, United States, 48093
Henry Ford West Bloomfield Hospital Recruiting
West Bloomfield, Michigan, United States, 48322
Contact: Ding Wang    888-734-5322      
Principal Investigator: Ding Wang         
Saint Mary's Oncology/Hematology Associates of West Branch Recruiting
West Branch, Michigan, United States, 48661
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
Metro Health Hospital Recruiting
Wyoming, Michigan, United States, 49519
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
IHA Hematology Oncology Consultants-Ann Arbor Recruiting
Ypsilanti, Michigan, United States, 48197
Contact: Christopher M. Reynolds    208-367-7954      
Principal Investigator: Christopher M. Reynolds         
United States, Minnesota
Sanford Clinic North-Bemidgi Recruiting
Bemidji, Minnesota, United States, 56601
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
Fairview Ridges Hospital Suspended
Burnsville, Minnesota, United States, 55337
Mercy Hospital Suspended
Coon Rapids, Minnesota, United States, 55433
Essentia Health Cancer Center Recruiting
Duluth, Minnesota, United States, 55805
Contact: Bret E. Friday    888-203-7267      
Principal Investigator: Bret E. Friday         
Essentia Health Saint Mary's Medical Center Suspended
Duluth, Minnesota, United States, 55805
Miller-Dwan Hospital Suspended
Duluth, Minnesota, United States, 55805
Fairview-Southdale Hospital Recruiting
Edina, Minnesota, United States, 55435
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Unity Hospital Suspended
Fridley, Minnesota, United States, 55432
Fairview Maple Grove Medical Center Suspended
Maple Grove, Minnesota, United States, 55369
Minnesota Oncology Hematology PA-Maplewood Suspended
Maplewood, Minnesota, United States, 55109
Saint John's Hospital - Healtheast Recruiting
Maplewood, Minnesota, United States, 55109
Contact: David M. King    888-823-5923    ctsucontact@westat.com   
Principal Investigator: David M. King         
Abbott-Northwestern Hospital Suspended
Minneapolis, Minnesota, United States, 55407
Hennepin County Medical Center Suspended
Minneapolis, Minnesota, United States, 55415
Health Partners Inc Suspended
Minneapolis, Minnesota, United States, 55454
New Ulm Medical Center Suspended
New Ulm, Minnesota, United States, 56073
North Memorial Medical Health Center Suspended
Robbinsdale, Minnesota, United States, 55422
Coborn Cancer Center at Saint Cloud Hospital Recruiting
Saint Cloud, Minnesota, United States, 56303
Contact: Donald J. Jurgens    877-229-4907    coborncancercenter@centracare.com   
Principal Investigator: Donald J. Jurgens         
Park Nicollet Clinic - Saint Louis Park Recruiting
Saint Louis Park, Minnesota, United States, 55416
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Regions Hospital Recruiting
Saint Paul, Minnesota, United States, 55101
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
United Hospital Suspended
Saint Paul, Minnesota, United States, 55102
Saint Francis Regional Medical Center Suspended
Shakopee, Minnesota, United States, 55379
Lakeview Hospital Suspended
Stillwater, Minnesota, United States, 55082
Ridgeview Medical Center Recruiting
Waconia, Minnesota, United States, 55387
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Rice Memorial Hospital Suspended
Willmar, Minnesota, United States, 56201
Minnesota Oncology Hematology PA-Woodbury Suspended
Woodbury, Minnesota, United States, 55125
Fairview Lakes Medical Center Suspended
Wyoming, Minnesota, United States, 55092
United States, Mississippi
Singing River Hospital Recruiting
Pascagoula, Mississippi, United States, 39581
Contact: James E. Clarkson    228-809-5292      
Principal Investigator: James E. Clarkson         
United States, Missouri
Central Care Cancer Center - Bolivar Recruiting
Bolivar, Missouri, United States, 65613
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Saint Francis Medical Center Recruiting
Cape Girardeau, Missouri, United States, 63703
Contact: Site Public Contact    573-334-2230    sfmc@sfmc.net   
Principal Investigator: Bryan A. Faller         
Centerpoint Medical Center LLC Suspended
Independence, Missouri, United States, 64057
Capital Region Southwest Campus Recruiting
Jefferson City, Missouri, United States, 65109
Contact: Bryan A. Faller    573-632-4814    swooden@mail.crmc.org   
Principal Investigator: Bryan A. Faller         
Research Medical Center Suspended
Kansas City, Missouri, United States, 64132
Heartland Regional Medical Center Recruiting
Saint Joseph, Missouri, United States, 64507
Contact: Jay W. Carlson    816-271-7937    linda.schumacher@mymlc.com   
Principal Investigator: Jay W. Carlson         
Saint Louis Cancer and Breast Institute-South City Suspended
Saint Louis, Missouri, United States, 63109
Missouri Baptist Medical Center Recruiting
Saint Louis, Missouri, United States, 63131
Contact: Bryan A. Faller    314-996-5569      
Principal Investigator: Bryan A. Faller         
Mercy Hospital Saint Louis Suspended
Saint Louis, Missouri, United States, 63141
CoxHealth South Hospital Suspended
Springfield, Missouri, United States, 65807
United States, Montana
Community Hospital of Anaconda Suspended
Anaconda, Montana, United States, 59711
Billings Clinic Cancer Center Recruiting
Billings, Montana, United States, 59101
Contact: Benjamin T. Marchello    800-996-2663    research@billingsclinic.org   
Principal Investigator: Benjamin T. Marchello         
Bozeman Deaconess Hospital Recruiting
Bozeman, Montana, United States, 59715
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Benefis Healthcare- Sletten Cancer Institute Recruiting
Great Falls, Montana, United States, 59405
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Great Falls Clinic Suspended
Great Falls, Montana, United States, 59405
Saint Peter's Community Hospital Suspended
Helena, Montana, United States, 59601
Kalispell Regional Medical Center Recruiting
Kalispell, Montana, United States, 59901
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Community Medical Hospital Suspended
Missoula, Montana, United States, 59804
United States, Nebraska
CHI Health Saint Francis Recruiting
Grand Island, Nebraska, United States, 68803
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Alegent Health Immanuel Medical Center Suspended
Omaha, Nebraska, United States, 68122
Alegent Health Bergan Mercy Medical Center Recruiting
Omaha, Nebraska, United States, 68124
Contact: Mehmet S. Copur    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Mehmet S. Copur         
Alegent Health Lakeside Hospital Suspended
Omaha, Nebraska, United States, 68130
University of Nebraska Medical Center Recruiting
Omaha, Nebraska, United States, 68198
Contact: Site Public Contact    402-559-6941    unmcrsa@unmc.edu   
Principal Investigator: Jairam Krishnamurthy         
United States, Nevada
Renown Regional Medical Center Suspended
Reno, Nevada, United States, 89502
Saint Mary's Regional Medical Center Recruiting
Reno, Nevada, United States, 89503
Contact: John A. Ellerton       protocols@swog.org   
Principal Investigator: John A. Ellerton         
United States, New Hampshire
New Hampshire Oncology Hematology PA-Concord Recruiting
Concord, New Hampshire, United States, 03301
Contact: Douglas J. Weckstein    603-224-2556      
Principal Investigator: Douglas J. Weckstein         
New Hampshire Oncology Hematology PA-Hooksett Recruiting
Hooksett, New Hampshire, United States, 03106
Contact: Douglas J. Weckstein    800-339-6484      
Principal Investigator: Douglas J. Weckstein         
Dartmouth Hitchcock Medical Center Recruiting
Lebanon, New Hampshire, United States, 03756
Contact: Mary D. Chamberlin    603-354-5454 ext 2155    jmichelson@cheshire-med.com   
Principal Investigator: Mary D. Chamberlin         
Norris Cotton Cancer Center-Manchester Recruiting
Manchester, New Hampshire, United States, 03102
Contact: Mary D. Chamberlin    603-354-5454 ext 2155    jmichelson@cheshire-med.com   
Principal Investigator: Mary D. Chamberlin         
Saint Joseph Hospital Suspended
Nashua, New Hampshire, United States, 03060
Norris Cotton Cancer Center-Nashua Recruiting
Nashua, New Hampshire, United States, 03063
Contact: Mary D. Chamberlin    603-354-5454 ext 2155    jmichelson@cheshire-med.com   
Principal Investigator: Mary D. Chamberlin         
United States, New Jersey
Hackensack University Medical Center Recruiting
Hackensack, New Jersey, United States, 07601
Contact: Deena M. Graham    201-996-2879      
Principal Investigator: Deena M. Graham         
The Cancer Institute of New Jersey Hamilton Recruiting
Hamilton, New Jersey, United States, 08690
Contact: Deborah L. Toppmeyer    609-631-6946      
Principal Investigator: Deborah L. Toppmeyer         
Saint Barnabas Medical Center Recruiting
Livingston, New Jersey, United States, 07039
Contact: Anna M. Litvak    973-322-2470      
Principal Investigator: Anna M. Litvak         
Monmouth Medical Center Recruiting
Long Branch, New Jersey, United States, 07740
Contact: Seth D. Cohen    732-923-7689      
Principal Investigator: Seth D. Cohen         
Virtua Memorial Recruiting
Mount Holly, New Jersey, United States, 08060
Contact: James W. Lee    609-914-6762      
Principal Investigator: James W. Lee         
MD Anderson Cancer Center at Cooper-Voorhees Recruiting
Voorhees, New Jersey, United States, 08043
Contact: Ahmed K. Abou Hussein    856-325-6757      
Principal Investigator: Ahmed K. Abou Hussein         
Virtua Voorhees Recruiting
Voorhees, New Jersey, United States, 08043
Contact: James W. Lee    609-914-6762      
Principal Investigator: James W. Lee         
United States, New Mexico
Lovelace Medical Center-Saint Joseph Square Suspended
Albuquerque, New Mexico, United States, 87102
University of New Mexico Cancer Center Recruiting
Albuquerque, New Mexico, United States, 87102
Contact: Ursa A. Brown-Glaberman    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Ursa A. Brown-Glaberman         
New Mexico Oncology Hematology Consultants Recruiting
Albuquerque, New Mexico, United States, 87109
Contact: Ursa A. Brown-Glaberman    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Ursa A. Brown-Glaberman         
Presbyterian Kaseman Hospital Recruiting
Albuquerque, New Mexico, United States, 87110
Contact: Ursa A. Brown-Glaberman    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Ursa A. Brown-Glaberman         
Memorial Medical Center - Las Cruces Recruiting
Las Cruces, New Mexico, United States, 88011
Contact: Ursa A. Brown-Glaberman    575-556-6545    Kim.Hoffman@lpnt.net   
Principal Investigator: Ursa A. Brown-Glaberman         
Presbyterian Rust Medical Center/Jorgensen Cancer Center Recruiting
Rio Rancho, New Mexico, United States, 87124
Contact: Ursa A. Brown-Glaberman    505-559-6113    WBurman@phs.org   
Principal Investigator: Ursa A. Brown-Glaberman         
Christus Saint Vincent Regional Cancer Center Recruiting
Santa Fe, New Mexico, United States, 87505
Contact: Ursa A. Brown-Glaberman    505-913-8933    Olivia.Sloan@nmcancercare.com   
Principal Investigator: Ursa A. Brown-Glaberman         
United States, New York
New York-Presbyterian/Brooklyn Methodist Hospital Recruiting
Brooklyn, New York, United States, 11215
Contact: Alan B. Astrow    718-780-3677    Adg9003@nyp.org   
Principal Investigator: Alan B. Astrow         
Roswell Park Cancer Institute Recruiting
Buffalo, New York, United States, 14263
Contact: Ellis G. Levine    877-275-7724      
Principal Investigator: Ellis G. Levine         
Arnot Ogden Medical Center/Falck Cancer Center Recruiting
Elmira, New York, United States, 14905
Contact: Serge Dauphin    607-271-7000      
Principal Investigator: Serge Dauphin         
Orange Regional Medical Center Suspended
Middletown, New York, United States, 10940
NYU Winthrop Hospital Suspended
Mineola, New York, United States, 11501
Mount Sinai Union Square Recruiting
New York, New York, United States, 10003
Contact: Paula Klein    212-824-7309    CCTO@mssm.edu   
Principal Investigator: Paula Klein         
Laura and Isaac Perlmutter Cancer Center at NYU Langone Recruiting
New York, New York, United States, 10016
Contact: Sylvia Adams    212-263-4434    prmc.coordinator@nyumc.org   
Principal Investigator: Sylvia Adams         
Mount Sinai West Suspended
New York, New York, United States, 10019
Mount Sinai Hospital Recruiting
New York, New York, United States, 10029
Contact: Paula Klein    212-824-7309    CCTO@mssm.edu   
Principal Investigator: Paula Klein         
Columbia University/Herbert Irving Cancer Center Recruiting
New York, New York, United States, 10032
Contact: Meghna S. Trivedi    212-305-6361    nr2616@cumc.columbia.edu   
Principal Investigator: Meghna S. Trivedi         
Weill Medical College of Cornell University Recruiting
New York, New York, United States, 10065
Contact: Eleni Andreopoulou    212-746-1848      
Principal Investigator: Eleni Andreopoulou         
Stony Brook University Medical Center Suspended
Stony Brook, New York, United States, 11794
State University of New York Upstate Medical University Recruiting
Syracuse, New York, United States, 13210
Contact: Abirami Sivapiragasam    315-464-5476      
Principal Investigator: Abirami Sivapiragasam         
Dickstein Cancer Treatment Center Suspended
White Plains, New York, United States, 10601
United States, North Carolina
Stanly Regional Medical Center Recruiting
Albemarle, North Carolina, United States, 28002
Contact: Julie G. Fisher    800-804-9376      
Principal Investigator: Julie G. Fisher         
Randolph Hospital Recruiting
Asheboro, North Carolina, United States, 27203
Contact: Vinay K. Gudena    336-832-0821      
Principal Investigator: Vinay K. Gudena         
Hope Women's Cancer Centers-Asheville Recruiting
Asheville, North Carolina, United States, 28816
Contact: Site Public Contact       protocols@swog.org   
Principal Investigator: Rachel E. Raab         
Cone Health Cancer Center at Alamance Regional Recruiting
Burlington, North Carolina, United States, 27215
Contact: Vinay K. Gudena    336-832-0821      
Principal Investigator: Vinay K. Gudena         
UNC Lineberger Comprehensive Cancer Center Recruiting
Chapel Hill, North Carolina, United States, 27599
Contact: Elizabeth C. Dees    877-668-0683    cancerclinicaltrials@med.unc.edu   
Principal Investigator: Elizabeth C. Dees         
Carolinas Medical Center/Levine Cancer Institute Recruiting
Charlotte, North Carolina, United States, 28203
Contact: Julie G. Fisher    704-355-2884      
Principal Investigator: Julie G. Fisher         
Levine Cancer Institute-Tryon Recruiting
Charlotte, North Carolina, United States, 28203
Contact: Julie G. Fisher    800-804-9376      
Principal Investigator: Julie G. Fisher         
Novant Health Presbyterian Medical Center Recruiting
Charlotte, North Carolina, United States, 28204
Contact: Nasfat Shehadeh    704-384-5369    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Oncology Specialists of Charlotte Recruiting
Charlotte, North Carolina, United States, 28207
Contact: Nasfat Shehadeh    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Carolinas Medical Center/Levine Cancer Institute-Pineville Recruiting
Charlotte, North Carolina, United States, 28210
Contact: Julie G. Fisher    800-804-9376      
Principal Investigator: Julie G. Fisher         
Southeastern Medical Oncology Center-Clinton Recruiting
Clinton, North Carolina, United States, 28328
Contact: James N. Atkins    252-399-7491      
Principal Investigator: James N. Atkins         
Carolinas HealthCare System NorthEast Recruiting
Concord, North Carolina, United States, 28025
Contact: Julie G. Fisher    704-403-1520      
Principal Investigator: Julie G. Fisher         
Southeastern Medical Oncology Center-Goldsboro Recruiting
Goldsboro, North Carolina, United States, 27534
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Cone Health Cancer Center Recruiting
Greensboro, North Carolina, United States, 27403
Contact: Vinay K. Gudena    336-832-0821      
Principal Investigator: Vinay K. Gudena         
Margaret R Pardee Memorial Hospital Recruiting
Hendersonville, North Carolina, United States, 28791
Contact: James E. Radford    828-696-1341      
Principal Investigator: James E. Radford         
Lake Norman Hematology Oncology Specialists-Huntersville Recruiting
Huntersville, North Carolina, United States, 28078
Contact: Nasfat Shehadeh    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Southern Oncology Specialists-Huntersville Suspended
Huntersville, North Carolina, United States, 28078
Southeastern Medical Oncology Center-Jacksonville Recruiting
Jacksonville, North Carolina, United States, 28546
Contact: James N. Atkins    888-774-0309      
Principal Investigator: James N. Atkins         
Novant Health Oncology Specialists-Kernersville Recruiting
Kernersville, North Carolina, United States, 27284
Contact: Erin S. Jepsen    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Erin S. Jepsen         
Vidant Oncology-Kinston Recruiting
Kinston, North Carolina, United States, 28501
Contact: Peter R. Watson    252-559-2200      
Principal Investigator: Peter R. Watson         
Novant Health Cancer Specialists-Matthews Recruiting
Matthews, North Carolina, United States, 28105
Contact: Nasfat Shehadeh    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Cone Heath Cancer Center at Mebane Suspended
Mebane, North Carolina, United States, 27302
Lake Norman Hematology Oncology Specialists-Mooresville Recruiting
Mooresville, North Carolina, United States, 28117
Contact: Nasfat Shehadeh    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Novant Health Oncology Specialists-Mount Airy Recruiting
Mount Airy, North Carolina, United States, 27030
Contact: Erin S. Jepsen    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Erin S. Jepsen         
Annie Penn Memorial Hospital Suspended
Reidsville, North Carolina, United States, 27320
Novant Health Oncology Specialists-Statesville Recruiting
Statesville, North Carolina, United States, 28625
Contact: Erin S. Jepsen    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Erin S. Jepsen         
Novant Health Oncology Specialists-Davidson County Recruiting
Thomasville, North Carolina, United States, 27360
Contact: Erin S. Jepsen    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Erin S. Jepsen         
Novant Health Oncology Specialists-Wilkesboro Recruiting
Wilkesboro, North Carolina, United States, 28659
Contact: Erin S. Jepsen    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Erin S. Jepsen         
Novant Health Forsyth Medical Center Recruiting
Winston-Salem, North Carolina, United States, 27103
Contact: Erin S. Jepsen    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Erin S. Jepsen         
Novant Health Oncology Specialists Recruiting
Winston-Salem, North Carolina, United States, 27103
Contact: Erin S. Jepsen    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Erin S. Jepsen         
United States, North Dakota
Sanford Bismarck Medical Center Recruiting
Bismarck, North Dakota, United States, 58501
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
Essentia Health Cancer Center-South University Clinic Recruiting
Fargo, North Dakota, United States, 58103
Contact: Bret E. Friday    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Roger Maris Cancer Center Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
Sanford Broadway Medical Center Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
Sanford Clinic North-Fargo Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
United States, Ohio
Cleveland Clinic Cancer Center Beachwood Suspended
Beachwood, Ohio, United States, 44122
UHHS-Chagrin Highlands Medical Center Suspended
Beachwood, Ohio, United States, 44122
Strecker Cancer Center-Belpre Recruiting
Belpre, Ohio, United States, 45714
Contact: Timothy D. Moore    800-523-3977    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Mercy Medical Center Recruiting
Canton, Ohio, United States, 44708
Contact: Mitchell Haut    888-293-4673      
Principal Investigator: Mitchell Haut         
Adena Regional Medical Center Recruiting
Chillicothe, Ohio, United States, 45601
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Case Western Reserve University Suspended
Cleveland, Ohio, United States, 44106
Cleveland Clinic Cancer Center/Fairview Hospital Recruiting
Cleveland, Ohio, United States, 44111
Contact: Aaron T. Gerds    866-223-8100    CancerAnswer@ccf.org   
Principal Investigator: Aaron T. Gerds         
Cleveland Clinic Foundation Recruiting
Cleveland, Ohio, United States, 44195
Contact: Aaron T. Gerds    866-223-8100    CancerAnswer@ccf.org   
Principal Investigator: Aaron T. Gerds         
Ohio State University Comprehensive Cancer Center Recruiting
Columbus, Ohio, United States, 43210
Contact: Sagar D. Sardesai    800-293-5066    Jamesline@osumc.edu   
Principal Investigator: Sagar D. Sardesai         
Mount Carmel East Hospital Suspended
Columbus, Ohio, United States, 43213
Columbus Oncology and Hematology Associates Inc Recruiting
Columbus, Ohio, United States, 43214
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Riverside Methodist Hospital Suspended
Columbus, Ohio, United States, 43214
Grant Medical Center Recruiting
Columbus, Ohio, United States, 43215
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
The Mark H Zangmeister Center Recruiting
Columbus, Ohio, United States, 43219
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Mount Carmel Health Center West Suspended
Columbus, Ohio, United States, 43222
Doctors Hospital Recruiting
Columbus, Ohio, United States, 43228
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Delaware Health Center-Grady Cancer Center Recruiting
Delaware, Ohio, United States, 43015
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Grady Memorial Hospital Suspended
Delaware, Ohio, United States, 43015
Mercy Cancer Center-Elyria Suspended
Elyria, Ohio, United States, 44035
Cleveland Clinic Cancer Center Independence Recruiting
Independence, Ohio, United States, 44131
Contact: Aaron T. Gerds    866-223-8100    CancerAnswer@ccf.org   
Principal Investigator: Aaron T. Gerds         
OhioHealth Mansfield Hospital Suspended
Mansfield, Ohio, United States, 44903
Cleveland Clinic Cancer Center Mansfield Recruiting
Mansfield, Ohio, United States, 44906
Contact: Aaron T. Gerds    866-223-8100    CancerAnswer@ccf.org   
Principal Investigator: Aaron T. Gerds         
Marietta Memorial Hospital Recruiting
Marietta, Ohio, United States, 45750
Contact: Timothy D. Moore    800-523-3977    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
OhioHealth Marion General Hospital Recruiting
Marion, Ohio, United States, 43302
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Hillcrest Hospital Cancer Center Recruiting
Mayfield Heights, Ohio, United States, 44124
Contact: Aaron T. Gerds    866-223-8100    CancerAnswer@ccf.org   
Principal Investigator: Aaron T. Gerds         
Lake University Ireland Cancer Center Suspended
Mentor, Ohio, United States, 44060
Southwest General Health Center Ireland Cancer Center Suspended
Middleburg Heights, Ohio, United States, 44130
Knox Community Hospital Suspended
Mount Vernon, Ohio, United States, 43050
Licking Memorial Hospital Recruiting
Newark, Ohio, United States, 43055
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
University Hospitals Parma Medical Center Suspended
Parma, Ohio, United States, 44129
Southern Ohio Medical Center Recruiting
Portsmouth, Ohio, United States, 45662
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Ireland Cancer Center at Firelands Regional Medical Center Suspended
Sandusky, Ohio, United States, 44870
North Coast Cancer Care Recruiting
Sandusky, Ohio, United States, 44870
Contact: Aaron T. Gerds    866-223-8100    CancerAnswer@ccf.org   
Principal Investigator: Aaron T. Gerds         
Trinity's Tony Teramana Cancer Center Recruiting
Steubenville, Ohio, United States, 43952
Contact: Dennis J. Meisner    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Dennis J. Meisner         
Cleveland Clinic Cancer Center Strongsville Recruiting
Strongsville, Ohio, United States, 44136
Contact: Aaron T. Gerds    866-223-8100    CancerAnswer@ccf.org   
Principal Investigator: Aaron T. Gerds         
Flower Hospital Recruiting
Sylvania, Ohio, United States, 43560
Contact: Abhijit B. Saste    419-824-1842      
Principal Investigator: Abhijit B. Saste         
The Toledo Hospital/Toledo Children's Hospital Active, not recruiting
Toledo, Ohio, United States, 43606
University Hospitals Sharon Health Center Suspended
Wadsworth, Ohio, United States, 44281
South Pointe Hospital Recruiting
Warrensville Heights, Ohio, United States, 44122
Contact: Aaron T. Gerds    866-223-8100    CancerAnswer@ccf.org   
Principal Investigator: Aaron T. Gerds         
Saint Ann's Hospital Suspended
Westerville, Ohio, United States, 43081
UH Seidman Cancer Center at Saint John Medical Center Suspended
Westlake, Ohio, United States, 44145
UHHS-Westlake Medical Center Suspended
Westlake, Ohio, United States, 44145
Cleveland Clinic Wooster Family Health and Surgery Center Recruiting
Wooster, Ohio, United States, 44691
Contact: Aaron T. Gerds    866-223-8100    CancerAnswer@ccf.org   
Principal Investigator: Aaron T. Gerds         
Genesis Healthcare System Cancer Care Center Recruiting
Zanesville, Ohio, United States, 43701
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
United States, Oklahoma
Cancer Centers of Southwest Oklahoma Research Recruiting
Lawton, Oklahoma, United States, 73505
Contact: Wajeeha Razaq    877-231-4440      
Principal Investigator: Wajeeha Razaq         
University of Oklahoma Health Sciences Center Recruiting
Oklahoma City, Oklahoma, United States, 73104
Contact: Wajeeha Razaq    402-559-6941    unmcrsa@unmc.edu   
Principal Investigator: Wajeeha Razaq         
Mercy Hospital Oklahoma City Suspended
Oklahoma City, Oklahoma, United States, 73120
United States, Oregon
Saint Alphonsus Medical Center-Baker City Suspended
Baker City, Oregon, United States, 97814
Providence Oncology and Hematology Care Southeast Suspended
Clackamas, Oregon, United States, 97015
Good Samaritan Hospital Recruiting
Corvallis, Oregon, United States, 97330
Contact: Site Public Contact    541-768-4352    stmock@samhealth.org   
Principal Investigator: David M. Hufnagel         
Legacy Mount Hood Medical Center Recruiting
Gresham, Oregon, United States, 97030
Contact: Jacqueline Vuky    503-413-2150      
Principal Investigator: Jacqueline Vuky         
Providence Newberg Medical Center Suspended
Newberg, Oregon, United States, 97132
Saint Alphonsus Medical Center-Ontario Recruiting
Ontario, Oregon, United States, 97914
Contact: Christopher M. Reynolds    734-712-3671      
Principal Investigator: Christopher M. Reynolds         
Legacy Good Samaritan Hospital and Medical Center Recruiting
Portland, Oregon, United States, 97210
Contact: Jacqueline Vuky    800-220-4937    cancer@lhs.org   
Principal Investigator: Jacqueline Vuky         
Providence Portland Medical Center Recruiting
Portland, Oregon, United States, 97213
Contact: Gary E. Goodman    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Gary E. Goodman         
Providence Saint Vincent Medical Center Suspended
Portland, Oregon, United States, 97225
Kaiser Permanente Northwest Recruiting
Portland, Oregon, United States, 97227
Contact: Sandeep H. Mashru    503-335-2400      
Principal Investigator: Sandeep H. Mashru         
Oregon Health and Science University Recruiting
Portland, Oregon, United States, 97239
Contact: Zahi Mitri    503-494-1080    trials@ohsu.edu   
Principal Investigator: Zahi Mitri         
SWOG Recruiting
Portland, Oregon, United States, 97239
Contact: Lajos Pusztai    203-785-5702      
Principal Investigator: Lajos Pusztai         
Legacy Meridian Park Hospital Recruiting
Tualatin, Oregon, United States, 97062
Contact: Jacqueline Vuky    503-413-1742      
Principal Investigator: Jacqueline Vuky         
United States, Pennsylvania
Abington Memorial Hospital Recruiting
Abington, Pennsylvania, United States, 19001
Contact: Willard G. Andrews    215-481-2402      
Principal Investigator: Willard G. Andrews         
Bryn Mawr Hospital Recruiting
Bryn Mawr, Pennsylvania, United States, 19010
Contact: Albert S. DeNittis    484-476-2649    ewend@mlhs.org   
Principal Investigator: Albert S. DeNittis         
Saint Vincent Hospital Recruiting
Erie, Pennsylvania, United States, 16544
Contact: Thomas B. Julian    814-452-5000      
Principal Investigator: Thomas B. Julian         
Jefferson Hospital Recruiting
Jefferson Hills, Pennsylvania, United States, 15025
Contact: Christie J. Hilton    724-226-7380      
Principal Investigator: Christie J. Hilton         
Riddle Memorial Hospital Recruiting
Media, Pennsylvania, United States, 19063
Contact: Albert S. DeNittis    484-476-2649    ewend@mlhs.org   
Principal Investigator: Albert S. DeNittis         
Forbes Hospital Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: Christie J. Hilton    724-226-7380      
Principal Investigator: Christie J. Hilton         
Paoli Memorial Hospital Recruiting
Paoli, Pennsylvania, United States, 19301
Contact: Albert S. DeNittis    484-476-2649    ewend@mlhs.org   
Principal Investigator: Albert S. DeNittis         
Thomas Jefferson University Hospital Recruiting
Philadelphia, Pennsylvania, United States, 19107
Contact: Maysa M. Abu-Khalaf    215-955-6084      
Principal Investigator: Maysa M. Abu-Khalaf         
Fox Chase Cancer Center Suspended
Philadelphia, Pennsylvania, United States, 19111
Allegheny General Hospital Recruiting
Pittsburgh, Pennsylvania, United States, 15212
Contact: Christie J. Hilton    724-226-7380      
Principal Investigator: Christie J. Hilton         
West Penn Hospital Recruiting
Pittsburgh, Pennsylvania, United States, 15224
Contact: Christie J. Hilton    724-226-7380      
Principal Investigator: Christie J. Hilton         
University of Pittsburgh Cancer Institute (UPCI) Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Contact: Rachel C. Jankowitz    412-647-2811      
Principal Investigator: Rachel C. Jankowitz         
Reading Hospital Recruiting
West Reading, Pennsylvania, United States, 19611
Contact: Terrence P. Cescon    610-988-9323      
Principal Investigator: Terrence P. Cescon         
Wexford Health and Wellness Pavilion Recruiting
Wexford, Pennsylvania, United States, 15090
Contact: Christie J. Hilton    412-359-3043    ddefazio@wpahs.org   
Principal Investigator: Christie J. Hilton         
UPMC Susquehanna Active, not recruiting
Williamsport, Pennsylvania, United States, 17701
Lankenau Medical Center Recruiting
Wynnewood, Pennsylvania, United States, 19096
Contact: Albert S. DeNittis    484-476-2649    turzoe@mlhs.org   
Principal Investigator: Albert S. DeNittis         
United States, South Carolina
AnMed Health Cancer Center Recruiting
Anderson, South Carolina, United States, 29621
Contact: John E. Doster    864-512-4651    rhonda.ballew@anmedhealth.org   
Principal Investigator: John E. Doster         
Medical University of South Carolina Recruiting
Charleston, South Carolina, United States, 29425
Contact: Antonio Giordano    843-792-9321    hcc-clinical-trials@musc.edu   
Principal Investigator: Antonio Giordano         
Greenville Health System Cancer Institute-Laurens Suspended
Clinton, South Carolina, United States, 29325
Greenville Health System Cancer Institute-Easley Suspended
Easley, South Carolina, United States, 29640
McLeod Regional Medical Center Recruiting
Florence, South Carolina, United States, 29506
Contact: Rajesh Bajaj    843-777-6387    jcapotosti@mcleodhealth.org   
Principal Investigator: Rajesh Bajaj         
Gibbs Cancer Center-Gaffney Suspended
Gaffney, South Carolina, United States, 29341
Saint Francis Hospital Recruiting
Greenville, South Carolina, United States, 29601
Contact: Robert D. Siegel    864-255-1713      
Principal Investigator: Robert D. Siegel         
Greenville Health System Cancer Institute-Butternut Suspended
Greenville, South Carolina, United States, 29605
Greenville Health System Cancer Institute-Faris Suspended
Greenville, South Carolina, United States, 29605
Saint Francis Cancer Center Recruiting
Greenville, South Carolina, United States, 29607
Contact: Robert D. Siegel    864-255-1713      
Principal Investigator: Robert D. Siegel         
Greenville Health System Cancer Institute-Eastside Suspended
Greenville, South Carolina, United States, 29615
Self Regional Healthcare Recruiting
Greenwood, South Carolina, United States, 29646
Contact: Antonio Giordano    864-725-4771      
Principal Investigator: Antonio Giordano         
Greenville Health System Cancer Institute-Greer Suspended
Greer, South Carolina, United States, 29650
Gibbs Cancer Center-Pelham Recruiting
Greer, South Carolina, United States, 29651
Contact: Steven W. Corso    800-486-5941      
Principal Investigator: Steven W. Corso         
South Carolina Cancer Specialists PC Recruiting
Hilton Head Island, South Carolina, United States, 29926-3827
Contact: Howard A. Zaren    912-819-5704      
Principal Investigator: Howard A. Zaren         
Levine Cancer Institute-Rock Hill Recruiting
Rock Hill, South Carolina, United States, 29732
Contact: Julie G. Fisher    800-804-9376      
Principal Investigator: Julie G. Fisher         
Greenville Health System Cancer Institute-Seneca Suspended
Seneca, South Carolina, United States, 29672
Spartanburg Medical Center Recruiting
Spartanburg, South Carolina, United States, 29303
Contact: Steven W. Corso    800-486-5941      
Principal Investigator: Steven W. Corso         
Greenville Health System Cancer Institute-Spartanburg Suspended
Spartanburg, South Carolina, United States, 29307
MGC Hematology Oncology-Union Recruiting
Union, South Carolina, United States, 29379
Contact: Steven W. Corso    800-486-5941      
Principal Investigator: Steven W. Corso         
United States, South Dakota
Sanford Cancer Center Oncology Clinic Recruiting
Sioux Falls, South Dakota, United States, 57104
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
Avera Cancer Institute Recruiting
Sioux Falls, South Dakota, United States, 57105
Contact: Amy K. Krie    888-634-7268    oncregulatory@avera.org   
Principal Investigator: Amy K. Krie         
Sanford USD Medical Center - Sioux Falls Recruiting
Sioux Falls, South Dakota, United States, 57117-5134
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
United States, Tennessee
Vanderbilt-Ingram Cancer Center Cool Springs Suspended
Franklin, Tennessee, United States, 37067
Thompson Cancer Survival Center Recruiting
Knoxville, Tennessee, United States, 37916
Contact: Jashmin K. Patel    865-331-1812      
Principal Investigator: Jashmin K. Patel         
Thompson Cancer Survival Center - West Recruiting
Knoxville, Tennessee, United States, 37932
Contact: Jashmin K. Patel    865-331-1812      
Principal Investigator: Jashmin K. Patel         
Thompson Oncology Group-Lenoir City Recruiting
Lenoir City, Tennessee, United States, 37772
Contact: Jashmin K. Patel    865-331-1812      
Principal Investigator: Jashmin K. Patel         
Vanderbilt Breast Center at One Hundred Oaks Suspended
Nashville, Tennessee, United States, 37204
Vanderbilt University/Ingram Cancer Center Recruiting
Nashville, Tennessee, United States, 37232
Contact: Brent N. Rexer    800-811-8480      
Principal Investigator: Brent N. Rexer         
Thompson Oncology Group-Oak Ridge Recruiting
Oak Ridge, Tennessee, United States, 37830
Contact: Jashmin K. Patel    865-331-1812      
Principal Investigator: Jashmin K. Patel         
United States, Texas
The Don and Sybil Harrington Cancer Center Recruiting
Amarillo, Texas, United States, 79106
Contact: Brian T. Pruitt    806-212-1985    gcravey@harringtoncc.org   
Principal Investigator: Brian T. Pruitt         
Lyndon Baines Johnson General Hospital Suspended
Houston, Texas, United States, 77026-1967
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Recruiting
Houston, Texas, United States, 77030
Contact: Julie R. Nangia    713-798-1354    burton@bcm.edu   
Principal Investigator: Julie R. Nangia         
Ben Taub General Hospital Suspended
Houston, Texas, United States, 77030
M D Anderson Cancer Center Recruiting
Houston, Texas, United States, 77030
Contact: Jennifer K. Litton    713-792-3245      
Principal Investigator: Jennifer K. Litton         
The Methodist Hospital System Suspended
Houston, Texas, United States, 77030
MD Anderson Regional Care Center-Katy Suspended
Houston, Texas, United States, 77094
MD Anderson Regional Care Center-Bay Area Suspended
Nassau Bay, Texas, United States, 77058
MD Anderson Regional Care Center-Sugar Land Suspended
Sugar Land, Texas, United States, 77478
Houston Methodist Sugar Land Hospital Recruiting
Sugar Land, Texas, United States, 77479
Contact: Site Public Contact    281-242-2873      
Principal Investigator: Tejal Patel         
MD Anderson Regional Care Center-The Woodlands Suspended
The Woodlands, Texas, United States, 77384
United States, Utah
Farmington Health Center Suspended
Farmington, Utah, United States, 84025
Huntsman Cancer Institute/University of Utah Recruiting
Salt Lake City, Utah, United States, 84112
Contact: Saundra S. Buys    801-581-4477    clinical.trials@hci.utah.edu   
Principal Investigator: Saundra S. Buys         
South Jordan Health Center Suspended
South Jordan, Utah, United States, 84009
United States, Vermont
Norris Cotton Cancer Center-North Recruiting
Saint Johnsbury, Vermont, United States, 05819
Contact: Mary D. Chamberlin    603-354-5454 ext 2155    jmichelson@cheshire-med.com   
Principal Investigator: Mary D. Chamberlin         
United States, Virginia
IMG Hematology Oncology 8501 Recruiting
Fairfax, Virginia, United States, 22031
Contact: Mary J. Wilkinson    703-720-5210    Stephanie.VanBebber@inova.org   
Principal Investigator: Mary J. Wilkinson         
Lynchburg Hematology-Oncology Clinic Recruiting
Lynchburg, Virginia, United States, 24501
Contact: Hetal R. Vachhani    434-200-5925    Kevin.Patel@centrahealth.com   
Principal Investigator: Hetal R. Vachhani         
Bon Secours Memorial Regional Medical Center Recruiting
Mechanicsville, Virginia, United States, 23116
Contact: William J. Irvin    877-668-0683    cancerclinicaltrials@med.unc.edu   
Principal Investigator: William J. Irvin         
Bon Secours Saint Francis Medical Center Recruiting
Midlothian, Virginia, United States, 23114
Contact: William J. Irvin    877-668-0683    cancerclinicaltrials@med.unc.edu   
Principal Investigator: William J. Irvin         
Bon Secours Saint Mary's Hospital Recruiting
Richmond, Virginia, United States, 23226
Contact: William J. Irvin    877-668-0683    cancerclinicaltrials@med.unc.edu   
Principal Investigator: William J. Irvin         
Virginia Cancer Institute Recruiting
Richmond, Virginia, United States, 23230
Contact: Hetal R. Vachhani    804-287-3000    david.trent@comcast.net   
Principal Investigator: Hetal R. Vachhani         
Virginia Commonwealth University/Massey Cancer Center Recruiting
Richmond, Virginia, United States, 23298
Contact: Hetal R. Vachhani       mwellons@vcu.edu   
Principal Investigator: Hetal R. Vachhani         
Shenandoah Oncology PC Recruiting
Winchester, Virginia, United States, 22601
Contact: Hetal R. Vachhani    540-662-1108    William.Houck@usoncology.com   
Principal Investigator: Hetal R. Vachhani         
United States, Washington
Harrison HealthPartners Hematology and Oncology-Bremerton Suspended
Bremerton, Washington, United States, 98310
Kadlec Clinic Hematology and Oncology Suspended
Kennewick, Washington, United States, 99336
Seattle Cancer Care Alliance at EvergreenHealth Suspended
Kirkland, Washington, United States, 98034
PeaceHealth Saint John Medical Center Suspended
Longview, Washington, United States, 98632
Skagit Valley Hospital Regional Cancer Care Center Suspended
Mount Vernon, Washington, United States, 98273
Skagit Valley Hospital Suspended
Mount Vernon, Washington, United States, 98274
Jefferson Healthcare Recruiting
Port Townsend, Washington, United States, 98368
Contact: John A. Keech    360-344-3091      
Principal Investigator: John A. Keech         
Harrison HealthPartners Hematology and Oncology-Poulsbo Suspended
Poulsbo, Washington, United States, 98370
Fred Hutchinson Cancer Research Center Suspended
Seattle, Washington, United States, 98109
Seattle Cancer Care Alliance Recruiting
Seattle, Washington, United States, 98109
Contact: Julie R. Gralow    800-422-6237      
Principal Investigator: Julie R. Gralow         
Swedish Medical Center-First Hill Recruiting
Seattle, Washington, United States, 98122-4307
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Seattle Cancer Care Alliance at Northwest Hospital Suspended
Seattle, Washington, United States, 98133
University of Washington Medical Center Suspended
Seattle, Washington, United States, 98195
Spokane Valley Cancer Center-Mayfair Suspended
Spokane, Washington, United States, 99208
PeaceHealth Southwest Medical Center Suspended
Vancouver, Washington, United States, 98664
Legacy Salmon Creek Hospital Recruiting
Vancouver, Washington, United States, 98686
Contact: Jacqueline Vuky    503-413-2150      
Principal Investigator: Jacqueline Vuky         
United States, West Virginia
Edwards Comprehensive Cancer Center Recruiting
Huntington, West Virginia, United States, 25701
Contact: Maria R. Tria Tirona    304-399-6617      
Principal Investigator: Maria R. Tria Tirona         
United States, Wisconsin
Langlade Hospital and Cancer Center Recruiting
Antigo, Wisconsin, United States, 54409
Contact: Harish G. Ahuja    715-623-9869    Juli.Alford@aspirus.org   
Principal Investigator: Harish G. Ahuja         
Saint Vincent Hospital Cancer Center Green Bay Recruiting
Green Bay, Wisconsin, United States, 54301
Contact: Matthew L. Ryan    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Matthew L. Ryan         
Saint Vincent Hospital Cancer Center at Saint Mary's Recruiting
Green Bay, Wisconsin, United States, 54303
Contact: Matthew L. Ryan       protocols@swog.org   
Principal Investigator: Matthew L. Ryan         
Gundersen Lutheran Medical Center Recruiting
La Crosse, Wisconsin, United States, 54601
Contact: David E. Marinier    608-775-2385    cancerctr@gundersenhealth.org   
Principal Investigator: David E. Marinier         
University of Wisconsin Hospital and Clinics Recruiting
Madison, Wisconsin, United States, 53792
Contact: Amye J. Tevaarwerk    800-622-8922      
Principal Investigator: Amye J. Tevaarwerk         
ProHealth D N Greenwald Center Recruiting
Mukwonago, Wisconsin, United States, 53149
Contact: Timothy R. Wassenaar    262-928-7632      
Principal Investigator: Timothy R. Wassenaar         
Cancer Center of Western Wisconsin Suspended
New Richmond, Wisconsin, United States, 54017
ProHealth Oconomowoc Memorial Hospital Recruiting
Oconomowoc, Wisconsin, United States, 53066
Contact: Timothy R. Wassenaar    262-928-7632      
Principal Investigator: Timothy R. Wassenaar         
ProHealth Waukesha Memorial Hospital Recruiting
Waukesha, Wisconsin, United States, 53188
Contact: Timothy R. Wassenaar    262-928-7632      
Principal Investigator: Timothy R. Wassenaar         
UW Cancer Center at ProHealth Care Recruiting
Waukesha, Wisconsin, United States, 53188
Contact: Timothy R. Wassenaar    262-928-7632      
Principal Investigator: Timothy R. Wassenaar         
Aspirus Regional Cancer Center Recruiting
Wausau, Wisconsin, United States, 54401
Contact: Harish G. Ahuja    877-405-6866      
Principal Investigator: Harish G. Ahuja         
Aspirus UW Cancer Center Recruiting
Wisconsin Rapids, Wisconsin, United States, 54494
Contact: Harish G. Ahuja    715-422-7718      
Principal Investigator: Harish G. Ahuja         
United States, Wyoming
Billings Clinic-Cody Suspended
Cody, Wyoming, United States, 82414
Puerto Rico
Cancer Center-Metro Medical Center Bayamon Recruiting
Bayamon, Puerto Rico, 00959-5060
Contact: Luis Baez-Diaz    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Luis Baez-Diaz         
Doctors Cancer Center Recruiting
Manati, Puerto Rico, 00674
Contact: Luis Baez-Diaz    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Luis Baez-Diaz         
San Juan Community Oncology Group Recruiting
San Juan, Puerto Rico, 00917
Contact: Luis Baez-Diaz    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Luis Baez-Diaz         
San Juan City Hospital Recruiting
San Juan, Puerto Rico, 00936
Contact: Luis Baez-Diaz    787-767-3733      
Principal Investigator: Luis Baez-Diaz         
Sponsors and Collaborators
National Cancer Institute (NCI)
Investigators
Principal Investigator: Lajos Pusztai Southwest Oncology Group

Responsible Party: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT02954874     History of Changes
Other Study ID Numbers: NCI-2016-01595
NCI-2016-01595 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )
S1418/BR006
s16-02231
S1418 ( Other Identifier: SWOG )
S1418 ( Other Identifier: CTEP )
U10CA180888 ( U.S. NIH Grant/Contract )
First Posted: November 4, 2016    Key Record Dates
Last Update Posted: July 16, 2018
Last Verified: June 2018

Additional relevant MeSH terms:
Carcinoma
Breast Neoplasms
Triple Negative Breast Neoplasms
Breast Carcinoma In Situ
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases
Carcinoma in Situ
Pembrolizumab
Antineoplastic Agents